Tapia v. NaphCare Inc
Opinion
1 2 3
4 5 UNITED STATES DISTRICT COURT 6 WESTERN DISTRICT OF WASHINGTON AT SEATTLE 7 JAVIER TAPIA, CASE NO. C22-1141-KKE 8
Plaintiff(s), ORDER ON MOTIONS TO STRIKE AND 9 v. MOTIONS TO EXCLUDE EXPERT TESTIMONY 10 NAPHCARE INC., et al.,
11 Defendant(s).
12 Plaintiff Javier Tapia sues Defendants NaphCare Inc. (“NaphCare”) and Pierce County (the 13 “County”) under 42 U.S.C. § 1983 and Washington state law, arguing that he received inadequate 14 medical care while detained at the Pierce County Jail. Tapia claims that Defendants’ denial or 15 delay of care directly caused the amputation of his leg. All parties retained experts to opine on 16 issues relating to Defendants’ liability and Tapia’s potential damages. Several motions to strike 17 or exclude expert witnesses are ripe for the Court’s consideration. Dkt. Nos. 109, 111, 113, 115, 18 116. 19 For the reasons below, the Court grants in part and denies in part each party’s motions to 20 exclude. Dkt. Nos. 109, 111, 113, 115, 116. 21 I. BACKGROUND 22 The Court provided a detailed factual background in its order on NaphCare’s motion for 23 summary judgment (Dkt. No. 186). The Court incorporates by reference the Background section 24 1 in that prior order, and for brevity, only recites the facts and procedural history as necessary for 2 context. 3 On June 10, 2024, both NaphCare and the County moved to strike or exclude testimony
4 from Tapia’s experts. Dkt. Nos. 109, 111, 113. The same day, Tapia also moved to exclude 5 NaphCare’s and the County’s expert testimony. Dkt. Nos. 115, 116. On August 1, 2024, the Court 6 held oral argument on these evidentiary motions and NaphCare’s motion for summary judgment. 7 Dkt. No. 151. On January 14, 2025, the Court denied NaphCare’s motion for summary judgment 8 on Tapia’s § 1983 Monell claim. Dkt. No. 186. On January 24, 2025, the Court granted in part 9 and denied in part Tapia’s motion for summary judgment. Dkt. No. 189. On January 27, 2025, 10 the Court granted in part and denied in part Pierce County’s motion for summary judgment. Dkt. 11 No. 190. The Court now turns to the parties’ pending motions to exclude. 12 II. LEGAL STANDARDS
13 A. Motion to Strike 14 Under Federal Rule of Civil Procedure 26, parties must disclose all expert reports “at the 15 times and in the sequence that the court orders.” Fed. R. Civ. P. 26(a)(2)(D). And a party must 16 also “supplement or correct its disclosure…in a timely manner if the party learns that in some 17 material respect the disclosure or response is incomplete or incorrect[.]” Fed. R. Civ. P. 18 26(e)(1)(A). “If a party fails to provide information…as required by Rule 26(a) or (e), the party 19 is not allowed to use that information or witness to supply evidence on a motion, at a hearing, or 20 at trial, unless the failure was substantially justified or is harmless.” Fed. R. Civ. P. 37(c)(1); see 21 also Goodman v. Staples the Office Superstore, LLC, 644 F.3d 817, 827 (9th Cir. 2011) (“Rule 22 37(c)(1) is a self-executing, automatic sanction designed to provide a strong inducement for
23 disclosure.” (cleaned up)). Rule 37 allows district courts to “properly impose an exclusion 24 sanction where a noncompliant party has failed to show that the discovery violation was either 1 substantially justified or harmless.” Merchant v. Corizon Health, Inc., 993 F.3d 733, 740 (9th Cir. 2 2021). 3 B. Motion to Exclude Expert Testimony
4 Federal Rule of Evidence 702 allows a “witness who is qualified as an expert by 5 knowledge, skill, experience, training, or education” to provide opinion testimony based on 6 “scientific, technical, or other specialized knowledge” if that knowledge will help the fact-finder 7 to “understand the evidence or to determine a fact in issue.” Fed. R. Evid. 702. Courts liberally 8 construe Rule 702 in favor of admissibility. See Daubert v. Merrell Dow Pharmas., Inc., 509 U.S. 9 579, 588 (1993). 10 Put simply, Rule 702 requires expert testimony to be both relevant and reliable. Hemmings 11 v. Tidyman’s Inc., 285 F.3d 1174, 1184 (9th Cir. 2002) (“Whether testimony is helpful within the 12 meaning of Rule 702 is in essence a relevancy inquiry.”); Daubert, 509 U.S. at 591 (“Expert
13 testimony which does not relate to any issue in the case is not relevant and, ergo, non-helpful.”); 14 see also Fed. R. Evid. 403 (permitting exclusion of relevant evidence if its probative value is 15 “substantially outweighed” by the danger of unfair prejudice, confusion of the issues, or 16 misleading the jury, among other concerns). 17 In considering the reliability of an expert’s testimony, the Court weighs whether (1) “the 18 testimony is based on sufficient facts or data[,]” (2) the expert uses reliable principles and methods, 19 and (3) the expert reliably applied the principles and methods to the instant facts. Fed. R. Evid. 20 702. The Supreme Court outlined a non-exhaustive list of factors1 for deciding the reliability of 21 scientific testimony, but these factors are not applicable to non-scientific testimony, which heavily 22
23 1 The Daubert factors for weighing the reliability of scientific testimony includes (1) whether the theory can be and has been tested, (2) whether it has been peer reviewed, (3) the known or potential rate of error, and (4) whether the theory used is generally accepted in the relevant scientific community. Daubert, 509 U.S. at 593–94. 24 1 depends on an expert’s experience and knowledge versus methodology. Hangarter v. Provident 2 Life & Accident Ins. Co., 373 F.3d 998, 1017 (9th Cir. 2004). 3 III. ANALYSIS
4 A. Motions to Exclude Tapia’s Experts 5 NaphCare and Pierce County move to exclude Tapia’s liability and damages experts: Dr. 6 Johnny Bates, Ms. Denise Panosky, Dr. Daphne Glindmeyer, Dr. Juan Carlos Jimenez, Dr. Hans 7 Carlson, Mr. Timothy Andenmatten, and Mr. Volkov. Dkt. Nos. 109, 111, 113. 8 1. Dr. Johnny E. Bates 9 Dr. Johnny Bates is a board-certified doctor with clinical experience in correctional 10 healthcare. Dkt. No. 104-8 at 14, 15. He currently manages a correctional healthcare company 11 with over 350 employees and previously worked as the corporate medical director at a NaphCare 12 facility in Alabama. Id. at 3, 16. Altogether, he has over 30 years of experience in correctional
13 healthcare as a clinician and manager. Id. at 3. 14 Both NaphCare and the County move to exclude and strike Dr. Bates’ expert testimony. 15 NaphCare seeks to exclude Dr. Bates because (1) he is unqualified to opine on Phlegmasia Cerulea 16 Dolens (“PCD”) because he had never encountered the disease in his practice before this case, (2) 17 Dr. Bates’ opinion that LPN Carillo practiced outside the scope of his license is contradicted by 18 Dr. Bates’ deposition testimony, and (3) Dr.
Free access — add to your briefcase to read the full text and ask questions with AI
1 2 3
4 5 UNITED STATES DISTRICT COURT 6 WESTERN DISTRICT OF WASHINGTON AT SEATTLE 7 JAVIER TAPIA, CASE NO. C22-1141-KKE 8
Plaintiff(s), ORDER ON MOTIONS TO STRIKE AND 9 v. MOTIONS TO EXCLUDE EXPERT TESTIMONY 10 NAPHCARE INC., et al.,
11 Defendant(s).
12 Plaintiff Javier Tapia sues Defendants NaphCare Inc. (“NaphCare”) and Pierce County (the 13 “County”) under 42 U.S.C. § 1983 and Washington state law, arguing that he received inadequate 14 medical care while detained at the Pierce County Jail. Tapia claims that Defendants’ denial or 15 delay of care directly caused the amputation of his leg. All parties retained experts to opine on 16 issues relating to Defendants’ liability and Tapia’s potential damages. Several motions to strike 17 or exclude expert witnesses are ripe for the Court’s consideration. Dkt. Nos. 109, 111, 113, 115, 18 116. 19 For the reasons below, the Court grants in part and denies in part each party’s motions to 20 exclude. Dkt. Nos. 109, 111, 113, 115, 116. 21 I. BACKGROUND 22 The Court provided a detailed factual background in its order on NaphCare’s motion for 23 summary judgment (Dkt. No. 186). The Court incorporates by reference the Background section 24 1 in that prior order, and for brevity, only recites the facts and procedural history as necessary for 2 context. 3 On June 10, 2024, both NaphCare and the County moved to strike or exclude testimony
4 from Tapia’s experts. Dkt. Nos. 109, 111, 113. The same day, Tapia also moved to exclude 5 NaphCare’s and the County’s expert testimony. Dkt. Nos. 115, 116. On August 1, 2024, the Court 6 held oral argument on these evidentiary motions and NaphCare’s motion for summary judgment. 7 Dkt. No. 151. On January 14, 2025, the Court denied NaphCare’s motion for summary judgment 8 on Tapia’s § 1983 Monell claim. Dkt. No. 186. On January 24, 2025, the Court granted in part 9 and denied in part Tapia’s motion for summary judgment. Dkt. No. 189. On January 27, 2025, 10 the Court granted in part and denied in part Pierce County’s motion for summary judgment. Dkt. 11 No. 190. The Court now turns to the parties’ pending motions to exclude. 12 II. LEGAL STANDARDS
13 A. Motion to Strike 14 Under Federal Rule of Civil Procedure 26, parties must disclose all expert reports “at the 15 times and in the sequence that the court orders.” Fed. R. Civ. P. 26(a)(2)(D). And a party must 16 also “supplement or correct its disclosure…in a timely manner if the party learns that in some 17 material respect the disclosure or response is incomplete or incorrect[.]” Fed. R. Civ. P. 18 26(e)(1)(A). “If a party fails to provide information…as required by Rule 26(a) or (e), the party 19 is not allowed to use that information or witness to supply evidence on a motion, at a hearing, or 20 at trial, unless the failure was substantially justified or is harmless.” Fed. R. Civ. P. 37(c)(1); see 21 also Goodman v. Staples the Office Superstore, LLC, 644 F.3d 817, 827 (9th Cir. 2011) (“Rule 22 37(c)(1) is a self-executing, automatic sanction designed to provide a strong inducement for
23 disclosure.” (cleaned up)). Rule 37 allows district courts to “properly impose an exclusion 24 sanction where a noncompliant party has failed to show that the discovery violation was either 1 substantially justified or harmless.” Merchant v. Corizon Health, Inc., 993 F.3d 733, 740 (9th Cir. 2 2021). 3 B. Motion to Exclude Expert Testimony
4 Federal Rule of Evidence 702 allows a “witness who is qualified as an expert by 5 knowledge, skill, experience, training, or education” to provide opinion testimony based on 6 “scientific, technical, or other specialized knowledge” if that knowledge will help the fact-finder 7 to “understand the evidence or to determine a fact in issue.” Fed. R. Evid. 702. Courts liberally 8 construe Rule 702 in favor of admissibility. See Daubert v. Merrell Dow Pharmas., Inc., 509 U.S. 9 579, 588 (1993). 10 Put simply, Rule 702 requires expert testimony to be both relevant and reliable. Hemmings 11 v. Tidyman’s Inc., 285 F.3d 1174, 1184 (9th Cir. 2002) (“Whether testimony is helpful within the 12 meaning of Rule 702 is in essence a relevancy inquiry.”); Daubert, 509 U.S. at 591 (“Expert
13 testimony which does not relate to any issue in the case is not relevant and, ergo, non-helpful.”); 14 see also Fed. R. Evid. 403 (permitting exclusion of relevant evidence if its probative value is 15 “substantially outweighed” by the danger of unfair prejudice, confusion of the issues, or 16 misleading the jury, among other concerns). 17 In considering the reliability of an expert’s testimony, the Court weighs whether (1) “the 18 testimony is based on sufficient facts or data[,]” (2) the expert uses reliable principles and methods, 19 and (3) the expert reliably applied the principles and methods to the instant facts. Fed. R. Evid. 20 702. The Supreme Court outlined a non-exhaustive list of factors1 for deciding the reliability of 21 scientific testimony, but these factors are not applicable to non-scientific testimony, which heavily 22
23 1 The Daubert factors for weighing the reliability of scientific testimony includes (1) whether the theory can be and has been tested, (2) whether it has been peer reviewed, (3) the known or potential rate of error, and (4) whether the theory used is generally accepted in the relevant scientific community. Daubert, 509 U.S. at 593–94. 24 1 depends on an expert’s experience and knowledge versus methodology. Hangarter v. Provident 2 Life & Accident Ins. Co., 373 F.3d 998, 1017 (9th Cir. 2004). 3 III. ANALYSIS
4 A. Motions to Exclude Tapia’s Experts 5 NaphCare and Pierce County move to exclude Tapia’s liability and damages experts: Dr. 6 Johnny Bates, Ms. Denise Panosky, Dr. Daphne Glindmeyer, Dr. Juan Carlos Jimenez, Dr. Hans 7 Carlson, Mr. Timothy Andenmatten, and Mr. Volkov. Dkt. Nos. 109, 111, 113. 8 1. Dr. Johnny E. Bates 9 Dr. Johnny Bates is a board-certified doctor with clinical experience in correctional 10 healthcare. Dkt. No. 104-8 at 14, 15. He currently manages a correctional healthcare company 11 with over 350 employees and previously worked as the corporate medical director at a NaphCare 12 facility in Alabama. Id. at 3, 16. Altogether, he has over 30 years of experience in correctional
13 healthcare as a clinician and manager. Id. at 3. 14 Both NaphCare and the County move to exclude and strike Dr. Bates’ expert testimony. 15 NaphCare seeks to exclude Dr. Bates because (1) he is unqualified to opine on Phlegmasia Cerulea 16 Dolens (“PCD”) because he had never encountered the disease in his practice before this case, (2) 17 Dr. Bates’ opinion that LPN Carillo practiced outside the scope of his license is contradicted by 18 Dr. Bates’ deposition testimony, and (3) Dr. Bates’ opinions on whether unconstitutional policies 19 existed is unreliable because they are based on insufficient facts. Dkt. No. 111 at 8–9, 14, 21. 20 NaphCare also seeks to specifically exclude Dr. Bates’ testimony that LPN Carillo acted outside 21 his scope of practice because it violates Federal Rules of Civil Procedure 26 and 37. Id. at 22. 22 The County argues that Dr. Bates’ testimony should be stricken because his opinions are
23 speculative, unreliable, and unhelpful to the jury because Dr. Bates could not identify what care 24 Tapia should have received or what mental health condition he likely had. Dkt. No. 109 at 9–10. 1 Further, the County challenges Dr. Bates’ testimony because in his opinion on whether deficient 2 policies existed at the Pierce County Jail, Dr. Bates did not identify a written policy or support his 3 conclusion with other detainees’ treatment. Id.
4 Neither Defendant has provided a sufficient basis to exclude Dr. Bates. 5 As an initial matter, Dr. Bates’ testimony does not violate Rule 26 or 37 because Tapia 6 timely disclosed his opinion, and his deposition testimony did not go beyond his expert report. 7 NaphCare relies on Brumley v. Pfizer, Inc., a case from the Southern District of Texas in which 8 the district court excluded an expert’s affidavit because it was untimely and added a theory of 9 causation that was not disclosed in the original report. 200 F.R.D. 596 (S.D. Tex. 2001). 10 Brumley is not analogous to Tapia’s case. In Brumley, the disputed expert affidavit was 11 submitted after the end of discovery and was “materially different” from the original expert report 12 because the affidavit proposed a new theory of causation connecting Viagra to cardiac risks. 200
13 F.R.D. at 603–04. The Brumley expert admitted that this theory was based on a report that he had 14 not read until after his original opinion was filed. Id. at 604. The district court also considered the 15 plaintiffs’ “discovery abuse by not proffering him for deposition in a timely manner,” thus 16 exacerbating prejudice to the defendant. Id. 17 Dr. Bates’ subsequent testimony on LPN Carillo’s conduct was not “materially different” 18 from his Rule 26 report. In his report, Dr. Bates reviewed LPN Carrillo’s testimony that he 19 reported Tapia’s symptoms back to the clinic Registered Nurse (“RN”) on September 19, 2018. 20 Dkt. No. 112-3 at 6. He opined that “[t]here is some question as to whether this actually occurred 21 in Mr. Tapia’s case because there is no documented record” and proceeded to provide a conclusion 22 based on specific hypotheticals, including whether LPN Carillo practiced outside the scope of his
23 license if he did report Tapia’s symptoms to the charge nurse. See id. (concluding that if LPN 24 Carillo had properly reported the symptoms, the charge nurse—not LPN Carillo—improperly 1 failed to conduct a follow-up). During his deposition testimony, NaphCare’s counsel posed the 2 same hypothetical, to which Dr. Bates gave the same answer. Dkt. No. 112-4 at 7–8. 3 Dr. Bates’ testimony does not include new or divergent theories in violation of Rule 26 or
4 37. He couches his opinions in hypothetical language in recognition that whether LPN Carillo 5 actually reported to an RN is a fact issue for the jury. And Ninth Circuit case law allows experts 6 to “address a hypothetical world that never existed.” Elosu v. Middlefork Ranch Inc., 26 F.4th 7 1017, 1025 (9th Cir. 2022). If NaphCare seeks to challenge inconsistencies between Dr. Bates’ 8 report and deposition, it should do so during cross-examination at trial. 9 The Court also rejects NaphCare’s argument that Dr. Bates should be excluded because he 10 had never encountered PCD in his practice. Dkt. No. 111 at 21. Dr. Bates does not opine on PCD 11 in his report. See Dkt. No. 112-3. When NaphCare’s counsel asked him to explain what PCD is 12 during his deposition, he provided a definition based on his general understanding as a medical
13 provider. Dkt. No. 112-4 at 5. The references to PCD made in his report and deposition “d[o] not 14 disqualify his opinions based on a lack of particularized experience.” City of Seattle v. Monsanto 15 Co., No. C16-107-RAJ-MLP, 2023 WL 4014294, at *11 (W.D. Wash. June 15, 2023). Moreover, 16 on the topics Dr. Bates does seek to offer opinions on, he is well-qualified to do so. Dkt. No. 104- 17 8 at 14. For example, Dr. Bates offers opinions on when subordinate health care staffers (such as 18 the MHPs or LPNs) should have reported to their supervisor, whether Tapia’s initial symptoms 19 were severe enough to require a full diagnostic evaluation, and what was reasonably expected of 20 the NaphCare supervisors (RNs and medical providers). Id. at 4, 5. 21 Additionally, NaphCare broadly requests the Court preclude Tapia’s experts from offering 22 testimony on whether “NaphCare maintain[ed] any alleged constitutionally deficient policy,
23 custom, or practice.” Dkt. No. 111 at 17, 8–9, 14, 21. To the extent NaphCare seeks to exclude 24 legal conclusions from Dr. Bates’ testimony, the Court agrees that “[e]xpert testimony is not proper 1 for issues of law[,]” such as whether a Monell policy exists or whether Pierce County is liable for 2 negligence. Crow Tribe of Indians v. Racicot, 87 F.3d 1039, 1045 (9th Cir. 1996). However, the 3 Court will not preclude Dr. Bates from testifying that “if it is not documented, it didn’t happen.”
4 See Dkt. No. 111 at 21. 5 The County’s objections are also unavailing. The County takes issue with Dr. Bates’ 6 failure to identify, with a reasonable degree of medical certainty, what treatment Tapia should have 7 received in prison or what illness he should have been diagnosed with. Dkt. No. 109 at 9. It is 8 true that Washington law requires medical expert testimony to be based on a “reasonable degree 9 of medical certainty[.]” Reese v. Stroh, 907 P.2d 282, 286 (Wash. 1995). But Dr. Bates explains 10 that he is unable to diagnose Tapia or identify what treatment he should have received because 11 “there is not enough documentation there.” Dkt. No. 110-5 at 10. Based on the symptoms that 12 were documented—that is, Tapia’s “decompensated” state—he provides an opinion on what
13 should have happened next: Pierce County should have completed a full diagnostic evaluation. 14 Dkt. No. 112-3 at 5. Dr. Bates’ opinion that Tapia’s medical file did not contain sufficient 15 information to support a diagnosis is helpful to the jury in deciding whether the County’s conduct 16 delayed Tapia’s PCD diagnosis, and ultimately, whether Pierce County was negligent. 17 The County also argues that Dr. Bates’ testimony should be excluded because he “listed 18 out other ‘policies’ but could not identify any other inmates he relied upon to determine those 19 established ‘policies.’” Dkt. No. 109 at 10. The County is incorrect. As the Court explained in 20 its prior order on NaphCare’s motion for summary judgment, a Monell policy can be founded upon 21 a pattern of conduct towards an individual. Oyenik v. Corizon Health Inc., 696 F. App’x 792, 794 22 (9th Cir. 2017) (“There is no case law indicating that a custom cannot be inferred from a pattern
23 of behavior toward a single individual[.]”) (unpublished); see also Manzo v. Cnty. of Santa Clara, 24 No. 17-CV-01099-BLF, 2020 WL 6940935, at *12 (N.D. Cal. Nov. 25, 2020) (“Although Oyenik 1 is not a precedential opinion, the observation about the state of Ninth Circuit law is unquestionably 2 correct.”). 3 As such, the Court denies NaphCare’s and the County’s motion to exclude Dr. Bates’
4 testimony. 5 2. Dr. Daphne Glindmeyer 6 Tapia retains Dr. Glindmeyer, a forensic psychiatrist, to opine on whether Tapia received 7 adequate medical and mental health treatment at Pierce County Jail. Dr. Glindmeyer is a licensed, 8 board-certified psychiatrist and currently works in private practice, providing psychiatric 9 evaluation and medication management services to child, adolescent, and adult clients. Dkt. No. 10 104-5 at 2. She has experience consulting for various state and local correctional institutions across 11 the country. Id. at 39–40. 12 The County challenges the reliability of Dr. Glindmeyer’s testimony, while NaphCare
13 argues Dr. Glindmeyer should be excluded because she “does not identify a single alleged 14 NaphCare policy in her report that is deficient. Nor did she identify any such alleged policy during 15 her deposition.” Dkt. No. 111 at 9, Dkt. No. 109 at 11. 16 These arguments are unpersuasive. First, the County argues that Dr. Glindmeyer should 17 be excluded because she concluded that certain National Commission on Correctional Healthcare 18 (“NCCHC”) Standards were violated, without citation to specific standards, requirements, or 19 definitions. Dkt. No. 109 at 11. The County also takes issue with Dr. Glindmeyer’s failure to 20 specify treatment that Plaintiff should have received between the time he was booked and 21 September 17, 2018, when he was transferred to mental health housing. Id. A review of the record 22 shows that Dr. Glindmeyer did set out the NCCHC standards at issue in her report and deposition
23 testimony. See Dkt. No. 110-6 at 7 (Dr. Glindmeyer’s deposition describing a “global 24 statement…from the NCCHC” that addresses “various difficulties that health care systems can 1 have with regard to providing access to care”), 9–10 (explanation on NCCHC’s definition of 2 “isolation” and “segregation” and standards for monitoring inmates in mental health housing); Dkt. 3 No. 104-5 at 29 (citing 2018 NCCHC standards for health services in jails), 30 (citing scientific
4 literature on effects of isolation and segregation), 30 (citing 2015 NCCHC standards for mental 5 health services in correctional facilities). 6 The County does not provide compelling authority requiring a greater level of specificity. 7 Dkt. No. 109 at 11–12. Indeed, the Ninth Circuit has recognized that “much of medical decision- 8 making relies on judgment—a process that is difficult to quantify or even to assess qualitatively.” 9 Primiano v. Cook, 598 F.3d 558, 565 (9th Cir. 2010), as amended (Apr. 27, 2010). District courts 10 in this circuit have also declined to exclude expert testimony for lack of detailed citations where 11 the expert adequately explained the basis for her opinion and the expert’s training, knowledge, and 12 experience demonstrate reliability. See, e.g., Witkin v. Lotersztain, No. 2:19-cv-0406 TLN KJN
13 P, 2022 WL 2276663, at *5 (E.D. Cal. June 23, 2022) (“Although Dr. Burgar did not describe in 14 detail how she arrived at her opinion, or expressly set forth the standard of care, Dr. Burgar 15 sufficiently disclosed the basis for her conclusion.”); Rapp v. NaphCare, Inc., No. 3:21-cv-05800- 16 DGE, 2023 WL 3983662, at *4 (W.D. Wash. June 13, 2023); Allphin v. Peter K. Fitness, LLC, 78 17 F. Supp. 3d 987, 993 (N.D. Cal. 2015) (“[A]n expert does not need to specifically say the words 18 ‘medical standard of care’ if he clearly, and specifically, describes what care a doctor, operating 19 under similar circumstances as the plaintiff’s treating physicians, would have exercised in treating 20 a similarly situated plaintiff.”). And again, the Court rejects the argument that Dr. Glindmeyer 21 should be excluded because she did not identify what care Tapia should have received. Like Dr. 22 Bates, Dr. Glindmeyer acknowledged the lack of assessments and documentation in Tapia’s
23 medical file, which limited her conclusions. Dkt. No. 110-6 at 13 (responding that she could not 24 1 identify care Tapia should have received between June 16, 2018, and September 18, 2018, because 2 “nothing was documented, so it’s hard to know”). 3 Next, the County contends that Dr. Glindmeyer’s testimony is deficient because she “could
4 not say to a reasonable degree of medical certainty if Tapia’s delirium was related in any way to 5 the [Deep Vein Thrombosis] DVT or PCD.” Dkt. No. 109 at 7. Rather, Dr. Glindmeyer opined 6 that underlying medical conditions that cause pain can trigger delirium and observed that Tapia’s 7 PCD developed the same time Tapia exhibited delirium. Dkt. No. 104-5 at 32, Dkt. No. 110-6 at 8 15 (“I’m saying whatever happened down there in that leg, the pain related to that caused 9 delirium.”). And while the County claims that this opinion is speculative, it does not challenge 10 the medical records Dr. Glindmeyer reviewed in reaching this conclusion or her qualifications to 11 opine on the causes of delirium. The County can challenge Dr. Glindmeyer’s opinion on the 12 connection between Tapia’s delirium and underlying DVT or PCD through cross-examination.
13 The County next asserts that Dr. Glindmeyer’s opinion on delirium must be excluded 14 because other expert opinions contradict it. Expert testimony cannot be admitted if it is 15 contradicted by indisputable facts in the record, but different experts can come to divergent 16 conclusions by using a different methodology. Dorn v. Burlington N. Santa Fe R.R. Co., 397 F.3d 17 1183, 1196 (9th Cir. 2005) (quoting Weinstein’s Federal Evidence § 702.05[3], at 702–80.12 to 18 702–80.13); Kauffman v. Manchester Tank & Equip. Co., No. 98–35218, 1999 WL 1103357, at 19 *2 (9th Cir. Dec. 3, 1999) (“Expert opinion is insufficient if it ‘is not supported by sufficient facts 20 to validate it in the eyes of the law, or when indisputable record facts contradict or otherwise render 21 the opinion unreasonable….’”) (quoting Rebel Oil Co. v. Atlantic Richfield Co., 51 F.3d 1421, 22 1436 (9th Cir. 1995)) (unpublished). Because this inquiry goes to weight and credibility, the jury
23 holds the “[a]uthority to determine the victor in such a ‘battle of expert witnesses[.]’” Humetrix, 24 Inc. v. Gemplus S.C.A., 268 F.3d 910, 919 (9th Cir. 2001). 1 NaphCare also fails to justify exclusion. NaphCare claims that Dr. Glindmeyer does not 2 identify deficient NaphCare practices and customs that caused Tapia’s constitutional injury. But 3 Dr. Glindmeyer provided opinions on whether LPN Carillo’s conduct met the standard of care on
4 September 19, alleged backlogs and understaffing at Pierce County Jail, and whether NCCHC 5 standards required NaphCare medical providers to visit Tapia daily. Dkt. No. 104-5 at 32; Dkt. 6 No. 137-2 at 9, 38–39. These opinions are relevant to NaphCare’s potential Monell liability. 7 As a result, the Court denies the motions to exclude Dr. Glindmeyer as an expert. 8 3. Denise Panosky 9 NaphCare challenges the reliability and relevancy of Denise Panosky’s testimony. Denise 10 Panosky is an RN with about 40 years of experience, including 25 years in an emergency 11 department. Dkt. No. 104-13 at 2. She is certified as a Forensic Clinical Nurse Specialist and 12 Correctional Health Professional, among other certifications. Id. Ms. Panosky served as a
13 workgroup member on the American Nurses Association (“ANA”) Correctional Task Force, 14 which worked to revise the ANA’s standards and scope of practice guides for correctional nurses. 15 None of NaphCare’s arguments provide a sufficient basis for exclusion. First, NaphCare 16 claims that Denise Panosky’s testimony is unhelpful to the jury and irrelevant because Ms. 17 Panosky opines that NaphCare employees’ negligent conduct caused Tapia’s injury. Dkt. No. 111 18 at 12. According to NaphCare, because Tapia’s negligence claim against NaphCare has been 19 dismissed, any testimony about NaphCare employees’ purported negligence is prejudicial and 20 likely to mislead or confuse the jury. Id. 21 Ms. Panosky’s opinions do not solely revolve around whether NaphCare employees 22 comported with applicable standards of care. Rather, Ms. Panosky opines that she found a repeated
23 and consistent pattern of NaphCare LPNs practicing outside of their license. See Dkt. No. 104-13 24 at 14 (“Based on the provision of care given to Mr. Tapia during this time period, it appears that 1 NaphCare had a custom and established practice of requiring LPNs to work outside of their nursing 2 scope of practice by independently completing assessments and/or making treatment decisions.”). 3 Moreover, the jury must determine the severity of NaphCare’s lack of care to decide whether any
4 allegedly deficient NaphCare policy demonstrates deliberate indifference. See Russell v. Lumitap, 5 31 F.4th 729, 741 (9th Cir. 2022) (“[A]lthough medical negligence is not by itself unconstitutional, 6 the care rendered can be so inadequate to the circumstances known to the medical staff as to 7 amount to deliberate indifference.”); see also Arnold v. Lewis, 803 F. Supp. 246, 256–57 (D. Ariz. 8 1992) (finding that “defendants provided grossly inadequate mental health care for plaintiff” which 9 “demonstrates deliberate indifference to plaintiff’s serious mental health care needs”). In other 10 words, whether NaphCare employees acted according to applicable medical standards of care is 11 an essential part of the jury’s calculus of whether NaphCare is liable under Monell. The Court will 12 not exclude Ms. Panosky for this reason, especially as NaphCare’s concerns regarding confusion
13 to the jury are better addressed through jury instructions. 14 Next, NaphCare contends that Ms. Panosky’s testimony is unreliable because she bases her 15 conclusions about the standard of care on California law. Dkt. No. 111 at 19. In support, 16 NaphCare cites an excerpt of Ms. Panosky’s deposition in which she answered a question about 17 Dr. Bates’ testimony regarding the nursing scope practiced at his Alabama facilities. Dkt. No. 18 137-3 at 21 (“Dr. Bates testified that nurses are allowed to perform focused assessments at his 19 facilities. Do you agree that—do you disagree that LPNs are permitted to perform focused 20 assessments?”). In this excerpt, Ms. Panosky answered and cited to a California statute. Id. This 21 singular reference to non-Washington sources for medical standards of care does not justify 22 excluding Ms. Panosky’s testimony. During her deposition and in her report, Ms. Panosky makes
23 clear she bases her opinions on Washington law. Dkt. No. 137-3 at 20–21, Dkt. No. 104-13 at 16 24 (citing WASH. REV. CODE § 18.79.060). 1 Similarly, NaphCare claims that Ms. Panosky’s testimony conflicts with local Washington 2 law because “it is in direct contrast to an advisory opinion issued by the Washington State Board 3 of Nursing [WABON].” Dkt. No. 111 at 19. NaphCare provides no citation to the authority or
4 further explanation of how Ms. Panosky’s testimony conflicts with this opinion, and as such, the 5 Court rejects this argument. 6 NaphCare also argues that Ms. Panosky’s testimony should be excluded because she bases 7 her conclusion that NaphCare had a practice of LPNs working outside their nursing scope solely 8 on Tapia’s care. Dkt. No. 111 at 15–16. Again, as the Court concluded in its order denying 9 NaphCare’s motion for summary judgment, a Monell custom can be established based on conduct 10 towards an individual. Dkt. No. 186 at 12–13; Oyenik, 696 F. App’x at 794. NaphCare fails to 11 provide persuasive authority directing a different result. 12 Lastly, NaphCare argues that Ms. Panosky’s testimony impermissibly weighs the evidence,
13 thus attempting to substitute her own judgment for the jury’s. Dkt. No. 111 at 20. However, “[an 14 expert’s] decision as to what evidence he found more persuasive does not mean his opinion is 15 subject to exclusion.” Stenson v. King Cnty., No. C23-1316-MJP, 2024 WL 5108472, at *9 (W.D. 16 Wash. Dec. 13, 2024), on reconsideration, No. C23-1316 MJP, 2024 WL 5202555 (W.D. Wash. 17 Dec. 23, 2024). NaphCare may cross-examine Ms. Panosky on her decision to rely on certain 18 evidence and discount other parts of the record, but the Court will not exclude her before trial. 19 As such, the Court denies NaphCare’s motion to exclude Denise Panosky. 20 4. Dr. Juan Carlos Jimenez 21 NaphCare seeks to exclude Dr. Juan Carlos Jimenez, Tapia’s medical expert on PCD. Dr. 22 Jimenez currently serves as the director of UCLA Gonda (Goldschmied) Venous Center. Dkt. No.
23 104-17 at 10. He is a board-certified surgeon with a specialty in vascular surgery. Id. at 11. He 24 has served as a vascular surgeon at three separate hospitals and medical centers. Id. 1 NaphCare asserts three arguments for exclusion: (1) Dr. Jimenez did not identify a deficient 2 NaphCare policy, established practice, or custom; (2) he is not a correctional officer and does not 3 have prior experience with healthcare protocols in a jail setting; and (3) Dr. Jimenez’s experiences
4 with PCD are “extremely dissimilar” to Tapia’s case. Dkt. No. 111 at 9–10, 17–18. First, as noted 5 in the Court’s order on NaphCare’s motion for summary judgment, Dr. Jimenez’s testimony goes 6 to whether Tapia’s onset PCD and other systemic manifestations could have manifested in mental 7 health changes and whether such changes should have alerted NaphCare and Pierce County 8 personnel to perform a full diagnostic assessment. See Dkt. No. 186, Dkt. No. 104-17 at 7–8. 9 These inquiries go to causation (i.e., whether but-for NaphCare’s delayed care, as perpetuated 10 through deficient policies, Tapia could have received an earlier diagnosis and better outcome). 11 Dkt. No. 104-17 at 8. Dr. Jimenez’s testimony need not “establish every element that the plaintiff 12 must prove, in order to be admissible.” Primiano, 598 F.3d at 565.
13 Second, NaphCare argues that Dr. Jimenez should be excluded because he lacks experience 14 in correctional logistics and healthcare. Dkt. No. 111 at 13. The Court disagrees. Dr. Jimenez 15 had not indicated that he intends to offer any opinion on NaphCare policies and procedures. And 16 NaphCare does not challenge Dr. Jimenez’s qualifications as a vascular surgeon and a PCD 17 specialist, nor does NaphCare specify a difference between the standard of care in correctional and 18 non-correctional medicine that would preclude Dr. Jimenez’s expertise from applying here. 19 Indeed, other district courts in this circuit have declined to exclude medical experts due to their 20 unfamiliarity with correctional medicine. See, e.g., Est. of Wilson v. Cnty. of San Diego, No. 3:20- 21 cv-00457-RBM-DEB, 2023 WL 8360011, at *4 (S.D. Cal. Dec. 1, 2023) (“Dr. Steinberg has 22 extensive experience in treating patients with CHF. And any lack of experience or knowledge
23 concerning the standards in correctional facilities goes to the weight, not admissibility[.]”); Ball v. 24 1 Kootenai Cnty., No. 2:14-cv-00246-EJL-CWD, 2016 WL 4974949, at *5 (D. Idaho Sept. 16, 2 2016). 3 Third, NaphCare argues that Dr. Jimenez’s testimony is unreliable because he offers
4 opinions “that are completely unsubstantiated by any medical reasoning” and are “based on 5 nothing but his own experience.” Dkt. No. 111 at 17–18. NaphCare is wrong. Dr. Jimenez has 6 disclosed what he relied on for his conclusions—Tapia’s medical and jail records, various 7 deposition transcripts, and other expert reports. Dkt. No. 104-17 at 4–5. He also details his 8 qualifications and explains the foundation for his expertise in treating venous diseases, including 9 DVT. Id. at 3 (describing 16 years of experience as a vascular specialist, including Dr. Jimenez’s 10 current position as director of the UCLA Goldschmied Venous Center and experience as a vascular 11 surgeon at three different medical centers). And in providing his conclusions, Dr. Jimenez also 12 cites to Tapia’s medical record and his interpretation of these materials. See id. at 6 (explanation
13 of Tapia’s diagnosis upon admission to Tacoma General Hospital, with citations to relevant 14 medical literature), 7 (estimating when the onset of Tapia’s PCD began based on how far advanced 15 Tapia’s left foot necrosis and gangrene was and the complications documented when he was 16 admitted to Tacoma General Hospital), 7–8 (opining on the clinical note written by Tapia’s 17 physician at the hospital and Tapia’s September 18 progress notes), 8 (providing opinions based 18 on Tapia’s clinical photos and Dr. Jimenez’s “experience treating similar patients”). In short, Dr. 19 Jimenez does not rely solely on his own experience for his conclusions. And despite NaphCare’s 20 objections, physicians and medical experts are permitted to rely on their experience in providing 21 opinions. Primiano, 598 F.3d at 565; Pajas v. Cty. of Monterey, No. 16-cv-00945-BLF, 2019 WL 22 188660, at *2 (N.D. Cal. Jan. 14, 2019) (“When the expert is a physician, it may be more
23 appropriate to focus on the physician’s experience rather than the Daubert factors.”). NaphCare 24 1 fails to articulate why Dr. Jimenez’s opinions are “unsubstantiated” and thus, necessitate 2 exclusion. 3 Finally, NaphCare claims that Dr. Jimenez made “statements in direct contradiction of
4 another of Plaintiff’s experts” during his deposition and that he relied on patient experiences that 5 are “extremely dissimilar” to Tapia’s case. Dkt. No. 111 at 18. Both arguments go to weight, not 6 admissibility. Again, any contradictions between Tapia’s experts can be elicited on cross- 7 examination. See Dorn, 397 F.3d at 1196. Likewise, the jury may evaluate Dr. Jimenez’s 8 credibility by comparing his prior experiences with PCD to Tapia’s case, but the Court will “not 9 exclude opinions merely because they are impeachable.” Alaska Rent-A-Car, Inc. v. Avis Budget 10 Grp., Inc., 738 F.3d 960, 969 (9th Cir. 2013). 11 Accordingly, the Court denies NaphCare’s motion to exclude Dr. Jimenez’s testimony. 12 5. Dr. Hans Carlson
13 NaphCare next seeks to exclude Dr. Hans Carlson, one of Tapia’s damages experts. Dr. 14 Carlson is a board-certified licensed physician with certifications as a Life Care Planner (“CLCP”) 15 and Physician Life Care Planner (“CPLCP”). Dkt. No. 114-24 at 7. He is a member of the 16 American Academy of Physician Life Care Planners. Id. His specialty is in physical medicine 17 and rehabilitation, and electrodiagnostic medicine. Id. at 8. 18 NaphCare first argues that Dr. Carlson and Mr. Andenmatten (another of Tapia’s damages 19 experts) both failed to specify the data they considered in reaching their conclusions. Specifically, 20 NaphCare argues that Dr. Carlson relied on materials located in his company’s database that were 21 not disclosed in his expert report or before his deposition, including Tapia’s “physical capacity 22 evaluation completed…on January 7, 2024” and the “examinee information form.” Dkt. No. 114-
23 14 at 18. During his deposition, Dr. Carlson testified that “[t]he notes became the report. All of 24 the information…that I used to determine this is in my report.” Dkt. No. 137-11 at 18–19. A 1 review of the record shows that Dr. Carlson’s report includes conclusions drawn from his physical 2 evaluation of and interview with Tapia. Dkt. No. 114-24 at 18–19, 49, 52. 3 In response, Tapia claims that Dr. Carlson testified that the evaluation form and
4 “workflow” notes are located in his company’s database and that he is unsure if they can be 5 extracted. Dkt. No. 135 at 7. Tapia claims that failure to provide the notes is not prejudicial 6 because “the notes became the report.” Id. 7 The Court disagrees. Despite Tapia’s argument that these notes cannot be extracted, it 8 appears that another expert, Mr. Andenmatten, cited to and relied upon these same materials. Dkt. 9 No. 114-19 at 41 (citing materials created by Dr. Carlson, including a physician consultation 10 report, physical capacity evaluation completed by Dr. Carlson on January 7, 2024, and a 11 catastrophic life care plan completed on January 17, 2024). 12 In response to requests from NaphCare, Tapia refused to timely disclose this information,
13 claiming that “source materials do not have to be turned over with an expert report as long as they 14 are identified in the report.” Dkt. No. 114-21 at 2. Tapia is wrong. Rule 26(a)(2)(B) requires 15 expert witnesses to provide “the facts or data considered by the witness in forming them.” 16 NaphCare is entitled to access all materials that Mr. Andenmatten and Dr. Carlson reviewed and 17 considered. “This is an affirmative disclosure obligation—an adverse party need not serve 18 discovery to obtain the information within the scope of the rule.” Eisen v. Day, No. 21-cv-05349- 19 VKD, 2024 WL 1244482, at *6 (N.D. Cal. Mar. 21, 2024). 20 Rule 37(c)(1) provides an “automatic” sanction that bars the use of improperly disclosed 21 evidence. Yeti by Molly, Ltd. v. Deckers Outdoor Corp., 259 F.3d 1101, 1106 (9th Cir. 2001). 22 That said, “[t]he automatic nature of the rule’s application does not mean that a district court must
23 exclude evidence that runs afoul of Rule 26(a) or (e)—Rule 37(c)(1) authorizes appropriate 24 sanctions ‘[i]n addition to or instead of [exclusion].’” Merchant, 993 F.3d at 740. “Rather, the 1 rule is automatic in the sense that a district court may properly impose an exclusion sanction where 2 a noncompliant party has failed to show that the discovery violation was either substantially 3 justified or harmless.” Id.
4 Here, the Court declines to exclude Dr. Carlson or Mr. Andenmatten based on their reliance 5 on these two improperly withheld materials. Rather, the Court orders Tapia to disclose the 6 following materials cited by Mr. Andenmatten and created by Dr. Carlson: 7 • Physician Consultation Report completed by Dr. Carlson 8 • Physical Capacity Evaluation completed by Dr. Carlson on January 7, 2024 9 Dkt. No. 114-19 at 41. To the extent NaphCare claims an additional deposition of either expert is 10 necessitated by the late disclosures, Tapia shall bear the costs of re-opening both depositions. Any 11 such deposition shall be limited solely to the newly disclosed materials. 12 Beyond NaphCare’s claims regarding non-disclosure, NaphCare argues that the Court
13 should exclude Dr. Carlson’s opinions on causation, life expectancy, emotional damages, and 14 prosthetics because he lacks expertise in these areas. Dkt. No. 113 at 6. According to NaphCare, 15 Tapia’s damages experts should limit their testimony to damages only. Id. at 17. In his response, 16 Tapia asserts that Dr. Volkov, Dr. Carlson, and Mr. Andenmatten will not offer opinions on 17 causation. Dkt. No. 135 at 11. NaphCare does not address this representation in its reply. See 18 Dkt. No. 139. Therefore, the Court declines to exclude Tapia’s damages experts on this basis. 19 With respect to life expectancy, NaphCare criticizes Dr. Carlson because 1) he testified 20 that he could not recall offering an opinion on life expectancy for an individual with historical or 21 current opioid abuse; and 2) because Dr. Carlson chose not to consider Tapia’s past drug use since 22 Tapia is currently sober. Dkt. No. 113 at 17, Dkt. No. 114-24. NaphCare does not explain why
23 further specialization from Dr. Carlson is necessary. Indeed, in cases involving individuals with a 24 history of drug abuse, courts have admitted life expectancy experts without specific experience in 1 life expectancy estimation for opioid users. See, e.g., Pajas v. Cty. of Monterey, , 2019 WL 2 188660, at *7 (admitting a cardiologist with training on opioid detoxification and experience 3 testifying at trial regarding life expectancy); see also Dkt. No. 114-14 at 11 (Dr. Carlson opining
4 that he had at least one other experience providing a life expectancy analysis for an opioid user). 5 Next, NaphCare asserts that Dr. Carlson is unqualified to opine on prosthetic components 6 and coding. Generally, medical coding systems consist of groups of codes that correspond to 7 specific procedures or diagnoses.2 These systems are used to track information about a patient’s 8 health condition in their medical record and in the medical billing process. In the context of 9 prosthetics, coding is used to categorize prosthetic devices relative to their componentry.3 10 Prosthetics coding allows prosthetic devices to be classified by function and pricing.4 As part of 11 his report, Dr. Carlson included a cost analysis of Tapia’s prosthetics, which required prosthetics 12 coding. Dkt. No. 114-24 at 61–62 (medical equipment and prosthetics summary), 68–69 13 (explanation of what coding system was used to determine cost of prosthetics), 89 (cost projection 14 for Tapia’s medical equipment). 15 NaphCare concedes that “Dr. Carlson regularly works with amputees,” but takes issue with 16 his reliance on a prosthetist in his team to complete coding for Tapia’s devices. Dkt. No. 113 at 17 18, Dkt. No. 114-14 at 6 (“I work with a prosthetist in our multidisciplinary clinic, so we will 18 discuss the needs and I will write the prescription, but the coding is done by the prosthetist.”). 19 Tapia does not respond to this argument. Indeed, while Dr. Carlson has provided life care planning 20
21 2 See What Is Medical Coding?, AAPC, https://www.aapc.com/resources/what-is-medical- coding?msockid=2a1c83e5afd06838356e969eae816979. 22 3 Dep’t of Veterans Affs., VHA Directive 1045(1), Coding, Market Analyses and Contract Guidance for Prosthetic 23 Limb and/or Custom Orthotic Device Procurement (Feb. 17, 2021), https://www.va.gov/vhapublications/ViewPublication.asp?pub_ID=8895.
24 4 Id. 1 for individuals with amputations, this more general expertise does not “ipso facto qualify him to 2 testify as an expert in all related areas.” Pavo Sols. LLC v. Kingston Tech. Co., Inc., No. 8:14-cv- 3 01352-JLS-KES, 2019 WL 8138163, at *14 (C.D. Cal. Nov. 20, 2019), aff’d, 35 F.4th 1367 (Fed.
4 Cir. 2022); Scolaro v. Vons Companies, Inc., No. 2:17-cv-01979-JAD-VCF, 2020 WL 8920999 5 (D. Nev. Mar. 2, 2020) (excluding testimony from a licensed nurse practitioner who lacked specific 6 experience with injuries in the extremities and regularly referred patients to orthopedists for such 7 problems). And during his deposition, he testified that he is “somewhat familiar with the coding 8 for prosthetics.” Dkt. No. 114-14 at 6. As for experience with prosthetic components themselves, 9 though Dr. Carlson would prescribe prosthetics for his patients, he would not complete fittings, 10 and he relied on a prosthetist to determine the appropriate specifications (e.g., socket shape, 11 suspension, etc.). Id. at 14. Tapia does not respond to this argument. Therefore, based on Dr. 12 Carlson’s testimony, the Court finds that he lacks experience to provide a reliable opinion on
13 prosthetic coding and components. 14 Lastly, NaphCare contends that Dr. Carlson’s testimony about Tapia’s mental health is 15 irrelevant because via communications between parties’ counsel, Tapia purportedly disclaimed 16 any damages “stemming from ‘a clinically diagnosable injury related to his mental health and 17 caused by NaphCare’s negligence or constitutional violations.” Dkt. No. 113 at 19 (citing Aldan 18 v. Home Depot USA Inc., No. 3:20-CV-05694-TL, 2023 WL 5630076, at *8 (W.D. Wash. Aug. 19 31, 2023)). The Court disagrees with NaphCare’s representation. Reading Tapia’s counsel’s 20 statements in context, he confirmed that “Plaintiff will not be asserting ‘something more than just 21 a claim of emotional distress[.]’” Dkt. No. 114-13 at 3. A review of Dr. Carlson’s report shows 22 that he does not provide a mental health diagnosis for Tapia or argue that Tapia experienced a
23 “clinically diagnosable [mental health] injury.” Id. Therefore, the Court declines to limit Dr. 24 Carlson’s testimony on emotional distress damages. 1 In conclusion, while the Court finds that wholesale exclusion of Dr. Carlson as an expert 2 is not required, Dr. Carlson’s is unqualified to testify on prosthetic coding and components. 3 Further, the Court directs Tapia to disclose Dr. Carlson’s Physician Consultation Report and
4 Physician Capacity Evaluation. Tapia must provide this information within 7 days of this order 5 and pay the costs of any additional deposition as directed above. 6 6. Timothy Andenmatten 7 Timothy Andenmatten is a Certified Rehabilitation Counselor and Certified Vocational 8 Evaluation Specialist with experience providing vocational evaluations, rehabilitation, and 9 counseling as well as labor market evaluation and job placement services for individuals with 10 disabilities. Dkt. No. 114-19 at 57. He regularly testifies as a vocational expert in social security 11 disability benefit adjudication hearings, and is a member of the American Board of Vocational 12 Experts. Id.
13 First, NaphCare argues that Mr. Andenmatten’s amended report should be excluded as 14 untimely. Dkt. No. 113 at 12. On February 5, 2024, Mr. Andenmatten submitted his initial report, 15 which was based on Tapia’s $18 hourly wage. See Dkt. No. 114-19. Mr. Andenmatten received 16 Tapia’s deposition a week later. Dkt. No. 137-13 at 2. During his deposition, Tapia had testified 17 that he made about $20.50 per hour. Dkt. No. 114-2 at 7. Expert reports were due by March 15, 18 2024. Dkt. No. 63. Mr. Andenmatten testified at his deposition on March 29, 2024, during which 19 he explained that Tapia’s deposition was not available to him when he submitted his report and 20 that his report was based on the $18 hourly wage. Dkt. No. 137-4 at 29–31. He also explained 21 that he would amend his report if he was directed to do so. Id. at 29. On April 19, 2024, Tapia 22 served Mr. Andenmatten’s and Dr. Volkov’s amended reports. Dkt. No. 114-15, Dkt. No. 114-16
23 at 5. Discovery closed on May 15, 2024. Dkt. No. 63. 24 1 In response to NaphCare’s motion, Tapia counters that Federal Rule of Civil Procedure 26 2 required Tapia to amend Mr. Andenmatten’s and Volkov’s reports and that any injury to NaphCare 3 is harmless. Dkt. No. 135 at 3. Tapia asserts that his deposition—and his updated hourly wage
4 information—was not available to Mr. Andenmatten before the initial expert report was submitted 5 on February 5, 2023. Id.; see Fed. R. Civ. P. 26(e)(1)(A). Tapia also asserts that even if Mr. 6 Andenmatten’s report was submitted after the disclosure deadline, his amended report does not 7 prejudice NaphCare. 8 Rule 37 bars use of improperly disclosed information at trial “unless the failure was 9 substantially justified or is harmless.” Goodman, 644 F.3d at 827; Fed. R. Civ. P. 37(c)(1). To 10 decide whether an improper disclosure is “either substantially justified or harmless,” Merchant, 11 993 F.3d at 740, the Court considers four factors: “(1) prejudice or surprise to the party against 12 whom the evidence is offered; (2) the ability of that party to cure the prejudice; (3) the likelihood
13 of disruption of the trial; and (4) bad faith or willfulness involved in not timely disclosing the 14 evidence.” Lanard Toys Ltd. v. Novelty, Inc., 375 F. App’x 705, 713 (9th Cir. 2010) (unpublished). 15 Here, while Mr. Andenmatten’s amended report is technically untimely, overall, the factors 16 disfavor striking the report. First, NaphCare likely suffered little surprise by the evidence offered. 17 NaphCare learned about Tapia’s higher hourly wage in February 2024, and used that information 18 during Mr. Andenmatten’s deposition the following month. Dkt. No. 114-6 at 23. Mr. 19 Andenmatten also told NaphCare that he would amend his report based on the higher hourly figure 20 if he was directed to do so. Id. Similarly, NaphCare had the ability to cure any potential prejudice. 21 Mr. Andenmatten provided his amended report a month before discovery closed. NaphCare could 22 have requested an extension from the Court to decide whether it needed to depose Mr.
23 Andenmatten a second time or otherwise seek further discovery. It did neither. Moreover, trial is 24 also unlikely to be disrupted by Mr. Andenmatten’s amended report. Trial is set for March 2025, 1 and NaphCare has not suggested or requested that discovery be reopened based on this expert 2 testimony. And lastly, while Tapia’s counsel has not explained why Mr. Andenmatten was not 3 provided updated salary information in February 2024, the ultimate revised report works in
4 NaphCare’s favor. Compare Dkt. No. 114-15 at 56 (amended report stating Tapia’s estimated loss 5 in annual earnings capacity is $10,148) with Dkt. No. 114-19 at 55 (original report estimating 6 Tapia’s loss in annual earnings capacity at $13,996). Therefore, it is unlikely that the untimely 7 disclosure resulted from bad faith or attempt at gamesmanship in the expert disclosure process. 8 As such, a Rule 37(c) sanction is unnecessary at this juncture. 9 Second, NaphCare substantively attacks Mr. Andenmatten’s opinion, arguing that his 10 opinion on Tapia’s loss of earning capacity is unreliable and speculative because Mr. Andenmatten 11 “assum[es] that Tapia would have held a full-time, well-paying job if his life continued on the 12 same path it was on prior to his injury.” Dkt. No. 139 at 8. According to NaphCare, “the entire
13 record refutes” Mr. Andenmatten’s opinion that but for Tapia’s amputation, he would have left 14 prison and maximized his earning capacity by maintaining full-time employment as a construction 15 worker. Dkt. No. 113 at 14. NaphCare also claims that Mr. Andenmatten failed to consider 16 Tapia’s employment history prior to incarceration, which had gaps and sometimes included part- 17 time jobs. Id. at 12. In response, Tapia argues that NaphCare’s argument constitutes a factual 18 dispute rather than a challenge to Mr. Andenmatten’s methodology. Dkt. No. 135 at 7–8. 19 NaphCare’s argument does not go to reliability, but rather to the weight of Mr. 20 Andenmatten’s testimony. Despite NaphCare’s representation of the record, during his deposition, 21 Mr. Andenmatten testified that he considered Tapia’s prior gaps in employment and type of 22 employment when he calculated Tapia’s loss of earning capacity. Dkt. No. 114-6 at 19, 20–21.
23 Mr. Andenmatten also testified that he reviewed Tapia’s past and current employment records. 24 Dkt. No. 114-6 at 6; see also Dkt. No. 114-2 at 7. While NaphCare takes issue with Mr. 1 Andenmatten’s conclusion and how he weighed Tapia’s past work experience, this issue should 2 be resolved by a fact-finder, not by the Court on a motion to exclude. NaphCare may cross- 3 examine Mr. Andenmatten on how he weighed Tapia’s employment history and present its own
4 expert testimony disagreeing with Mr. Andenmatten’s method. But conflicting expert testimony 5 or mere disagreement with an expert’s conclusion does not render an expert wholly unreliable. 6 See City of Pomona v. SQM N. Am. Corp., 750 F.3d 1036, 1049 (9th Cir. 2014) (“Where two 7 credible experts disagree, it is the job of the fact finder, not the trial court, to determine which 8 source is more credible and reliable.”). 9 Lastly, NaphCare argues that Mr. Andenmatten’s “amended report undermines his initial 10 report” and is an “implicit[t] conce[ssion] that the information was central to the report and its 11 exclusion would mean his opinion on loss of earnings was not based on ‘sufficient data or facts.’” 12 Dkt. No. 113 at 15. This argument is unpersuasive. NaphCare does not argue that Mr.
13 Andenmatten changed his methodology, which Mr. Andenmatten explains in his report. Dkt. No. 14 114-19 at 6–8. Rather, Mr. Andenmatten revised his report to include Tapia’s updated wage 15 estimate, and testified during his deposition that such change in the factual input would necessarily 16 impact his overall calculations. Dkt. No. 137-4 at 30–31. Further, Mr. Andenmatten’s testimony 17 cannot be fairly taken as an admission that he relied on insufficient data when procedurally, experts 18 are permitted to amend their reports if they encounter new information. Fed. R. Civ. P. 26(e); see 19 Medtronic Vascular, Inc. v. Abbott Cardiovascular Sys., Inc., No. C-06-1066PJH(EMC), 2008 20 WL 4601038, at *2 (N.D. Cal. Oct. 15, 2008) (denying motion to strike a supplemental report 21 where the report included “nothing more than honest mistakes” and did not indicate an “attempt 22 to mask inadequate preparation of the original report”).
23 Thus, for the above reasons, the Court denies NaphCare’s motion to exclude Timothy 24 Andenmatten’s testimony. 1 7. Nik Volkov 2 Dr. Nik Volkov is a forensic economist with a practice focused on calculating economic 3 damages in cases involving personal injury, wrongful death, wrongful termination, intellectual
4 property, and commercial torts. Dkt. No. 114-20 at 26. He holds a Ph.D. in finance and 5 certifications as a Certified Valuation Analysis and Master Analyst in Financial Forensics. Id. 6 Altogether, he has more than seven years of experience as a forensic economist and business 7 valuator. Id. 8 NaphCare first argues that Dr. Volkov’s reports should be excluded because they rely on 9 Mr. Andenmatten’s purportedly flawed reports. Dkt. No. 113 at 15–16. Because the Court finds 10 that Mr. Andenmatten’s reports are sufficiently reliable to satisfy the Daubert standard, Dr. 11 Volkov’s reliance on Mr. Andenmatten’s opinions is not a proper basis for exclusion. 12 Next, NaphCare asserts that Dr. Volkov lacks specialization in life expectancy or work-life
13 expectancy. In particular, NaphCare claims that “Volkov expressly disclaimed being an expert on 14 life expectancy and work-life expectancy” and therefore, his conclusions on which work-life 15 expectancy table to use should not be offered. Dkt. No. 113 at 17–18. However, Dr. Volkov does 16 not seek to offer an opinion on Tapia’s life expectancy. Instead, Dr. Volkov testified that he used 17 a life expectancy source to compute “full-function life expectancy”, which is then used in 18 calculating loss of household services. Dkt. No. 137-12 at 24–26. He distinguished between work- 19 life expectancy estimates in forensic economics and the broader field of life expectancy, stating 20 that “these are two distinctly different methodologies with distinctly different objectives.” Id. at 21 28. Moreover, NaphCare does not attack the reliability of the life expectancy tables Dr. Volkov 22 uses, nor does it address the cases in which federal courts have allowed economist experts to rely
23 on similar sources in calculating household expenses and services. See, e.g., Myers-Clark v. 24 Frahler Elec. Co., No. C05-5553 JKA, 2007 WL 189248, at *1–2 (W.D. Wash. Jan. 22, 2007). 1 Lastly, NaphCare challenges the reliability of Dr. Volkov’s conclusions on loss of 2 household services, arguing that Dr. Volkov’s opinions are flawed because he relies on Tapia’s 3 representations as to the time he spent doing various activities prior to his injury. Dkt. No. 113 at
4 16. NaphCare also claims that Dr. Volkov did not consider other changes in Tapia’s life pre- and 5 post-injury, such as the fact that Tapia “was not working prior to his injury but is working 6 presently.” Id. To NaphCare, “Tapia’s change in employment status accounts for the entire 7 difference in Tapia’s household hours worked.” Id. (emphasis omitted). In other words, NaphCare 8 claims that Dr. Volkov ignored alternative explanations in Tapia’s loss of household services, and 9 thus should be excluded. 10 NaphCare’s arguments are better suited for cross-examination at trial. Dr. Volkov testified 11 that a juror could weigh Tapia’s credibility and conclude that his loss of hours was due more to 12 his consistent employment than his injury. Dkt. No. 137-12 at 22. Therefore, NaphCare’s
13 challenge to Dr. Volkov hinges on credibility determinations rather than on Dr. Volkov’s 14 methodology or qualifications, which is insufficient to survive a Daubert motion. See Primiano, 15 598 F.3d at 565 (“[T]he district judge is a gatekeeper, not a fact finder.”); City of Pomona, 750 16 F.3d at 1053 (“Facts casting doubt on the credibility of an expert witness and contested facts 17 regarding the strength of a particular scientific method are questions reserved for the fact finder.”). 18 Therefore, the Court denies NaphCare’s motion to exclude Dr. Volkov. 19 B. Motions to Exclude NaphCare’s Experts 20 Tapia moves to exclude or limit the opinions of Dr. Alan Abrams, Dr. Peter Crum, Kathryn 21 Wild, and Dr. Benjamin Starnes. Dkt. No. 115. 22 1. Dr. Alan Abrams
23 Dr. Alan Abrams is a licensed psychiatrist with a background in correctional, adult, 24 forensic, and addiction psychiatry and addiction medicine. Dkt. No. 117-1 at 3. He served as the 1 director of the Forensic Psychiatry Fellowship Program at Georgetown Medical School, a chief 2 psychiatrist at two California prisons, and the medical director at an inpatient psychiatric hospital 3 at the California Medical Facility (CMF – Vacaville)—a state prison. Id. He currently serves as
4 a forensic psychiatry instructor for residency training at the University of California, San Diego. 5 Id. Tapia seeks to exclude Dr. Abrams’ opinions relating to Tapia’s life expectancy, purported 6 “selective mutism,” and Tapia’s vascular disorders. Dkt. No. 115 at 3, 6, 8. He also moves to 7 exclude Dr. Abrams’ opinion that Tapia verbally refused meals. Id. at 7. 8 Tapia asserts that Dr. Abrams’ opinions about Tapia’s life expectancy are unreliable 9 because Dr. Abrams provides no methodology, statistics, or scientific principles that form the basis 10 for this opinion. Dkt. No. 115 at 3. NaphCare counters that this opinion is properly supported and 11 within Dr. Abrams’ scope of expertise as a specialist in addiction psychiatry and addiction 12 medicine. Dkt. No. 131 at 9. Dr. Abrams also cites various academic sources documenting how
13 substance use can affect life spans, though as Tapia points out, these sources do not appear to 14 account for the impact of prior substance use on life expectancy where the former user is now 15 sober. Dkt. No. 132-3 at 35, Dkt. No. 145 at 2. 16 The Court will not exclude Dr. Abrams’ testimony as to Tapia’s life expectancy. Rather, 17 he can be cross-examined on the alleged lack of support for his conclusions. However, Dr. 18 Abrams’ opinion on Tapia’s life expectancy is also partly based on his own determination that 19 Tapia’s self-report of sobriety since 2018 is not credible, or that Tapia is likely to relapse. Dkt. 20 No. 117-2 at 54. Dr. Abrams does not explain how his conclusions as to Tapia’s life expectancy 21 would change if the jury were to find Tapia credible. Accordingly, while the Court agrees with 22 NaphCare that Dr. Abrams is generally qualified to opine on the effect of Tapia’s past opioid use
23 on his estimated life expectancy, Dr. Abrams may not offer opinions on whether Tapia’s self- 24 report regarding his sobriety is credible. Rhine v. Buttigieg, No. 2:20-cv-01761-RAJ-BAT, 2022 1 WL 7729817, at *4 (W.D. Wash. Sept. 15, 2022) (“[W]hether a witness is truthful or accurate is 2 generally not a proper subject for expert testimony as it infringes upon the jury’s role and does not 3 assist the trier of fact.”). Rather, NaphCare may attack Tapia’s or his expert’s credibility on cross-
4 examination. 5 Tapia next asserts that Dr. Abrams’ opinion that Tapia had “selective mutism” should be 6 excluded as unreliable. The Court disagrees. Dr. Abrams based this conclusion on his experience 7 and training, and his review of the record that included instances in which Tapia verbally 8 communicated with medical providers. Dkt. No. 117-1 at 12 (explaining what “selective mutism” 9 is and why he believed selective mutism to be more likely than other potential medical illnesses). 10 Tapia’s disagreement with Dr. Abrams’ conclusions is not a proper basis for exclusion under 11 Daubert. Kennedy v. Collagen Corp., 161 F.3d 1226, 1230 (9th Cir. 1998). 12 Tapia then argues that Dr. Abrams’ conclusion that Tapia verbally refused meals should
13 be excluded because whether Tapia was verbally communicating during this period is under 14 dispute. Dkt. No. 115 at 7–8. In response, NaphCare argues that Dr. Abrams merely summarized 15 Tapia’s behavior log. The Court will not exclude Dr. Abrams based on his decision to rely on 16 some parts of the record and discount others. Stenson, 2024 WL 5108472, at *9. On cross- 17 examination, Tapia may challenge Dr. Abrams’ reliance on the behavior log and question whether 18 Pierce County or NaphCare employees correctly documented Tapia’s behavior. 19 As mentioned in the Court’s order on NaphCare’s motion for summary judgment, there is 20 sufficient evidence from which the jury could conclude that the documentation that Tapia was able 21 to speak (and subsequently refuse care or meals) was inaccurate. Therefore, Dr. Abrams cannot 22 definitively conclude that “Tapia verbally communicated with Pierce County personnel about his
23 meals.” Dkt. No. 117-1 at 13. That said, while it is appropriate to limit Dr. Abrams’ testimony on 24 this issue, Tapia has not shown that Dr. Abrams is unreliable and should be excluded. 1 Tapia asserts that Dr. Abrams’ testimony should be excluded because he offers unqualified 2 opinions relating to vascular disorders. Dkt. No. 115 at 8. The Court is unpersuaded. Dr. Abrams 3 acknowledged he would defer to a vascular surgeon for issues related to vascular disorders. Dkt.
4 No. 117-2 at 31. And Tapia does not challenge Dr. Abrams’ qualifications as a psychiatrist, nor 5 explain why he would be unqualified to opine on Tapia’s mental health symptoms as they were 6 related to his vascular conditions. Dkt. No. 115 at 8–9. 7 The Court denies Tapia’s motion to exclude Dr. Abrams and finds his testimony admissible 8 subject to the limitations explained above. 9 2. Dr. Peter Crum 10 Dr. Peter Crum is a board-certified internist who has practiced medicine in the correctional 11 setting for 29 years and served as the medical director for the Denver Sheriff’s Department for 17 12 years. Dkt. No. 117-10 at 2. He is accredited through the NCCHC, the American Correctional
13 Association, and the Commission on Accreditation for Law Enforcement Agencies. Id. Tapia 14 argues Dr. Crum’s testimony should be excluded for four reasons. None are persuasive. 15 First, Tapia claims that Dr. Crum offers the opinion that “Tapia had a behavior issue 16 involving the creation of illegal prison alcohol while incarcerated,” which Tapia argues is not 17 based on reliable facts and is prejudicial to the jury. Dkt. No. 115 at 12. NaphCare responds that 18 Dr. Crum is merely summarizing Tapia’s behavior log, and as such, there is no opinion to strike. 19 Dkt. No. 131 at 15–16. Tapia’s complaint is better suited to a motion in limine, as he attacks the 20 prejudicial nature of the underlying facts Dr. Crum relies on more so than the expert’s 21 qualifications or reliability. As such, the Court declines to exclude Dr. Crum on this basis. 22 Tapia then argues that Dr. Crum should be barred from offering opinions on nursing
23 standards because he has never been licensed as a nurse. Dkt. No. 115 at 12. Tapia also points 24 1 out that Dr. Crum lacks experience supervising RNs and LPNs, as he typically oversees higher 2 level medical staff. Dkt. No. 117-12 at 7–9. 3 In response, NaphCare argues that Dr. Crum’s experience as the medical director at the
4 Denver Sheriff Department qualifies him to opine on nursing standards. Dkt. No. 131 at 16. To 5 support its opposition, NaphCare filed a declaration from Dr. Crum, in which the expert explained 6 that he “clinically supervise[s] nurses, both [LPNs] and [RNs].” Dkt. No. 133. Tapia opposes 7 reliance on this declaration, claiming Dr. Crum impermissibly offers new opinions to buttress his 8 expert report outside the discovery deadline. Dkt. No. 145 at 5 n.2. 9 Courts allow experts to clarify or explain their reports or qualifications via declaration, but 10 experts are barred from “substantively supplementing their opinions outside of the expert report.” 11 Johnson v. Kelly, No. C16-0635JLR, 2017 WL 1838140, at *6 (W.D. Wash. May 8, 2017) 12 (citations omitted). The Court finds that this supplemental declaration provides clarification of the
13 extent of supervision Dr. Crum has over the nursing staff at the Denver Sheriff Department. Dkt. 14 No. 133 at 2 (“To properly clinically supervise the nurses at my facility, I know the scope of 15 practice for their different licenses and what type of assessments each license permits.”). Dr. 16 Crum’s position at the Denver Sheriff Department was disclosed in his expert report and he 17 discussed this role during his deposition. Thus, this declaration does not constitute improper 18 substitution or expansion outside of this report, and the Court declines to strike this declaration 19 from the record. 20 Tapia further asserts that Dr. Crum’s opinions on nursing standards “pertain[ed] solely to 21 Washington statute and [a] Department of Health advisory opinion” that was not in effect during 22 the relevant period. Dkt. No. 115 at 12. NaphCare counters that Dr. Crum did not solely depend
23 on this source material, and that these sources are relevant because the statute underlying the 24 advisory opinion was passed six years prior to Tapia’s incarceration. Dkt. No. 131 at 17 n.8 (citing 1 WASH. REV. CODE § 18.79.270), see also Dkt. No. 132-16. Dr. Crum’s alleged reliance on 2 inapplicable materials is a proper subject for cross-examination, and the Court will not exclude 3 him on this basis.
4 Next, Tapia contends that Dr. Crum’s opinion regarding NaphCare’s cost-saving incentives 5 is unreliable. Dkt. No. 115 at 13. According to Tapia, Dr. Crum only “helps develop medical 6 policies and protocols in his role as medical director for Denver Health”—a government entity— 7 as opposed to a for-profit correctional corporation like NaphCare. Id. This particularized 8 challenge is inappropriate for a Daubert motion. The Court agrees that Dr. Crum’s role as a 9 medical director, which includes overseeing correctional facilities’ staffing levels, is sufficient to 10 enable him to opine on this topic. Dkt. No. 132-1 at 16–17 (comparing NaphCare’s staffing levels 11 and composition to the Denver Sheriff Medical Department, which Dr. Crum explains is NCCHC 12 accredited). To the extent Tapia has further criticisms of Dr. Crum’s basis for comparison, he may
13 address them via cross-examination at trial. 14 Lastly, Tapia claims that Dr. Crum is unqualified to offer rebuttal opinions for Denise 15 Panosky, Dr. Glindmeyer, and Dr. Jimenez because he lacks their expertise and specialization in 16 nursing, psychiatry, and venous diseases. Dkt. No. 115 at 14–15. For the same reasons stated 17 above, the Court finds that Dr. Crum is qualified to provide a rebuttal report to Ms. Panosky’s 18 opinions because of his experience supervising nurses at the Denver Sheriff Medical Department. 19 This motion is denied with regard to Dr. Crum’s rebuttal to Ms. Panosky’s report. 20 However, the Court agrees that Dr. Crum is not qualified to opine on Tapia’s mental health 21 or standards of care for mental health generally because he lacks experience supervising MHPs 22 and specialization in psychiatry. That said, to the extent that Dr. Crum’s rebuttal addresses Dr.
23 Glindmeyer’s conclusions regarding the medical staff’s potential negligence, Dr. Crum is qualified 24 to provide those opinions. See Dkt. No. 132-17 at 6 (discussing whether NaphCare’s medical staff 1 neglected to perform a medical assessment on September 19). Tapia’s motion is thus granted in 2 part and denied in part as to Dr. Crum’s rebuttal to Dr. Glindmeyer’s report. 3 Likewise, Dr. Crum is also not qualified to rebut Dr. Jimenez’s opinion because he lacks
4 experience in vascular diseases. While Dr. Jimenez’s demonstrated experience in this specialty 5 allows him to opine on when Tapia began to exhibit early warning signs of compartment syndrome 6 and PCD—diseases which Defendants have both emphasized are rare—Dr. Crum lacks the 7 requisite specialization to rebut Dr. Jimenez’s conclusions. Avila v. Willits Envtl. Remediation Tr., 8 633 F.3d 828, 839 (9th Cir. 2011) (“[L]ack of specialization may go to weight only as long as an 9 expert stays within the reasonable confines of his subject area.” (cleaned up)) (finding that while 10 an expert had chemistry degrees, nothing in the record showed that he had special training 11 regarding metal working industries). For example, Dr. Crum states without basis that 12 “[c]ompartment syndrome is not typically associated with mental status changes.” Dkt. No. 132-
13 17 at 5. It is unclear to the Court what authority Dr. Crum bases his opinion on since he lacks 14 clinical experience with compartment syndrome. As such, the Court grants Tapia’s motion to 15 exclude Dr. Crum’s rebuttal opinions to Dr. Jimenez’s report. 16 3. Kathryn Wild 17 Kathryn Wild is a licensed RN who holds a master’s degree in public administration. Dkt. 18 No. 117-14 at 2. She is certified as a Corrections Healthcare Professional – RN by NCCHC. Id. 19 She has worked in the corrections healthcare field for over 30 years as an RN and health services 20 administrator (“HSA”). Id. Tapia argues that Ms. Wild’s report “consists entirely of conclusory 21 opinions” and should thus be excluded as unreliable, not based on sound principles or methods, 22 and unhelpful. Dkt. No. 115 at 15. Tapia offers three ways in which Ms. Wild’s report is
23 purportedly unreliable. None of these reasons provide sufficient basis for exclusion. 24 1 First, Tapia claims that Ms. Wild’s opinion on cost-saving incentives is not founded on 2 sufficient data or reliable principles. Ms. Wild opines that “there is no evidence in the documents 3 reviewed that NaphCare policies, procedures, and customs encouraged profit over care.” Dkt. No.
4 117-14 at 27. To show that Ms. Wild’s conclusions lack basis, Tapia points to Ms. Wild’s 5 deposition testimony, in which Ms. Wild stated that her determination of cost control measures 6 was based only on evaluating offsite care. Dkt. No. 117-15 at 17–18. According to Tapia, Ms. 7 Wild then “backtracked” on her answer. Id. at 20–21. 8 This argument goes to weight, rather than admissibility. Ms. Wild’s report shows that she 9 based her conclusions on NaphCare’s cost control measures on review of the staffing levels at 10 Pierce County Jail, NaphCare and Pierce County’s Personal Services Agreement, which made the 11 County financially responsible for off-site services such as referral to a hospital, and records 12 showing that once Tapia was reported to have discoloration on his foot, he was brought to the
13 clinic for evaluation and referred out the same day. Dkt. No. 117-14 at 25–26. “Shaky but 14 admissible evidence is to be attacked by cross examination, contrary evidence, and attention to the 15 burden of proof, not exclusion.” Primiano, 598 F.3d at 564. 16 Second, Tapia characterizes Ms. Wild’s opinion that “all NaphCare policies, procedures, 17 and customs met national standards” as hyperbolic and beyond her scope of expertise. Dkt. No. 18 115 at 16. Tapia further takes issue with Ms. Wild’s deposition testimony in which she admitted 19 that she did not review all the nursing assessment protocols themselves. Dkt. No. 117-15 at 14. 20 But Ms. Wild clarifies during the same deposition that protocols are distinct from NaphCare 21 policies and procedures. Id. at 7–8. When asked whether in preparing her opinion, she reviewed 22 all of NaphCare’s policies and procedures, she answered affirmatively. Id. at 11. Not every
23 NaphCare protocol is relevant to Tapia’s case, and Tapia fails to identify what key protocol Ms. 24 Wild failed to consider that justifies exclusion. 1 Third, Tapia takes issue with Ms. Wild’s credentials, arguing that her expertise does not 2 allow her to opine on whether NaphCare’s policies met national standards because she “cannot 3 create policies for providers with a different or higher licensure without consulting with them” as
4 an RN with a master’s degree in public health administration. Dkt. No. 115 at 18. But Ms. Wild 5 has experience in “corrections healthcare policy formation and implementation [and 6 maintenance]” from her years working as a health services administrator. Dkt. No. 117-14 at 2. 7 Tapia does not explain why her experience is deficient or renders her unqualified in this area. 8 As such, the Court denies NaphCare’s motion to exclude her testimony. 9 4. Rebuttal Opinions by Dr. Abrams, Kathryn Wild, and Dr. Benjamin Starnes 10 Tapia moves to exclude Dr. Abrams’, Kathryn Wild’s, and Dr. Benjamin Starnes’ rebuttal 11 opinions because they purportedly constitute improper rebuttal and improperly expand upon their 12 original opinions. Dkt. No. 115 at 6, 12, 18. Federal Rule of Civil Procedure 26(a)(2)(D) requires
13 parties to “make [expert] disclosures at the times and in the sequence that the court orders.” Absent 14 a stipulation or court order, parties must make expert disclosures “within 30 days after the other 15 party’s disclosure” “if the evidence is intended solely to contradict or rebut evidence on the same 16 subject matter identified by another party under Rule 26(a)(2)(B) or (C)[.]” Fed. R. Civ. P. 17 26(a)(2)(D)(ii). 18 To qualify as a rebuttal report, an expert’s report must “address the same subject matter as 19 another party’s expert report and must be intended solely to contradict or rebut that report.” U.S. 20 Bank, N.A. v. Glogowski Law Firm, PLLC, 339 F.R.D. 579, 580 (W.D. Wash. 2021) (holding that 21 a rebuttal opinion may contradict or rebut anticipated evidence); Rapp,2023 WL 3983662, at *2. 22 Tapia’s arguments here are sparse. In fact, for Dr. Abrams, he fails to identify or cite
23 exactly which portions of the expert’s report allegedly constitute improper rebuttal. Dkt. No. 115 24 at 6. As for his arguments on Kathryn Wild and Dr. Starnes, Tapia provides the conclusory 1 statement that each expert’s report contains improper rebuttal without any further explanation. Id. 2 at 12, 18. The Court therefore denies Tapia’s motion with respect to these experts. 3 C. Motions to Exclude the County’s Experts
4 Tapia seeks to exclude Pierce County’s experts, including Dr. Andrew Nanton, Dr. Kaj 5 Johansen, Dr. Molly Timmerman, Gary Berke, Shelley Lewis, and Eric Knowles.5 Tapia’s motion 6 is granted in part and denied in part. 7 1. Dr. Andrew Nanton 8 Dr. Andrew Nanton is a forensic psychiatrist with a specialty in child and adolescent 9 psychiatry. Dkt. No. 117-19 at 2. He has employment experience in juvenile and adult corrections, 10 inpatient, and outpatient settings. Id. He previously worked at Sacramento County Jail, Oregon 11 State Hospital, and Oregon Youth Authority, the latter of which manages inmates up to age 23. 12 Id. at 2–3. 13 Tapia seeks to exclude certain opinions by Dr. Nanton. Dkt. No. 116 at 4–5. Specifically, 14 Tapia argues that portions of Dr. Nanton’s rebuttal report fail to properly rebut any other expert 15 opinion, and thus, should be excluded. Id. at 4, Dkt. No. 117-20. Tapia identifies four sections 16 where Dr. Nanton purportedly offered no rebuttal or presented a new conclusory opinion unrelated 17 to Tapia’s experts’ opinions: “Jail Mental Health,” “Drug Induced Psychosis,” “Life Expectancy,” 18 and “Summary.” Dkt. No. 116 at 4. 19 The “Jail Mental Health” section of Dr. Nanton’s report addresses the same subject matter 20 as Dr. Glindmeyer’s report—whether Pierce County’s mental health staff adequately monitored 21 Tapia. Dr. Glindmeyer opined that Pierce County failed to properly monitor Tapia because under 22 NCCHC standards, inmates in acute mental health residential units like Tapia should be visited
5 Eric Knowles, Shelley Lewis, Dr. Molly Timmerman, and Dr. Gary Berke provided identical rebuttal reports for 24 both NaphCare and Pierce County. 1 daily. Dkt. No. 104-5 at 30–31. Dr. Nanton disagrees with Dr. Glindmeyer’s opinion, finding that 2 Pierce County’s documented frequency and pattern of visits meets NCCHC guidelines and Pierce 3 County’s written policy. Dkt. No. 117-20 at 5.
4 Similarly, Dr. Nanton’s opinion on whether drug-induced psychosis can cause brief 5 changes in mental statuses is proper rebuttal to Dr. Glindmeyer’s opinions. Dr. Glindmeyer 6 reviewed Tapia’s toxicology screen in reaching her conclusions and observed that the toxicology 7 screen was negative in concluding that his changed mental status indicated delirium. Dkt. No. 8 110-6 at 13, 48. In his rebuttal report, Dr. Nanton noted that he “he could not find the urine drug 9 screen mentioned by Dr. Glindmeyer” but that such “documentation would not change [his] 10 opinion if it did not show any detected substances.” Dkt. No. 117-20 at 5–6. Despite Tapia’s 11 contentions, this conclusion contradicts Dr. Glindmeyer’s opinion. 12 That said, Dr. Nanton’s opinion on drug-induced psychosis should be excluded as
13 speculative. Dr. Nanton cannot rely on any positive drug screening because there is none in the 14 record. Dkt. No. 117-20 at 5–6. He admits that it is not his opinion that Tapia’s altered mental 15 status was caused by drug-induced psychosis (Dkt. No. 117-21 at 5), but nonetheless that he 16 “cannot conclude that [drug induced-psychosis] is more likely than not the cause of Mr. Tapia’s 17 mental status changes.” Dkt. No. 117-20 at 6. In his deposition, he concedes that while in his 18 general experience, it is possible to obtain illicit substances in jails, he “did not see any specific 19 mention of Mr. Tapia using substances” nor did he review any other inmate’s information showing 20 use of drugs at Pierce County Jail during Tapia’s incarceration. Dkt. No. 117-21 at 5. In the 21 Court’s view, Dr. Nanton’s opinion that Tapia could have been using illicit substances and that the 22 drug use could have caused his mental status changes is based on his general understanding that
23 drugs like methamphetamine are typically undetectable via drug screening within a few days of 24 use. Dkt. No. 117-20 at 6. Dr. Nanton relies on nothing else in the record, and Pierce County does 1 not respond to Tapia’s argument. Dkt. No. 128 at 3. This is insufficient to satisfy Rule 702 and 2 the Daubert test. See A.B. v. Cnty. of San Diego, No. 18cv1541-MMA-LL, 2020 WL 4431982, at 3 *13 (S.D. Cal. July 31, 2020) (excluding a medical expert’s opinion that decedent was potentially
4 under the use of opioids because he did not see a negative toxicology screen in the medical 5 records). As such, the Court excludes Dr. Nanton’s opinion on drug-induced psychosis. 6 Tapia claims that Dr. Nanton’s opinion on life expectancy is improper because “he simply 7 agrees with another defense expert’s opinion.” Dkt. No. 116 at 4. The Court agrees. Dr. Nanton 8 quotes an excerpt from Dr. Abrams’ opinion, which concluded that Tapia’s life expectancy is about 9 53 years because the average life span of a heroin and opioid user is “on average about 20 years 10 less than normal[.]” Dkt. No. 117-20 at 6. Dr. Nanton opines that “the conclusion of a 20-year 11 reduction in expected life span…is reasonable, if not conservative[.]” Id. Dr. Nanton offers no 12 other opinions on Dr. Abrams’ report. Because his observation is consistent with Dr. Abrams’
13 analysis, the Court excludes the “Life Expectancy” section of Dr. Nanton’s report as improper 14 rebuttal.6 15 Tapia contends that in the “Summary” section, Dr. Nanton offered a new conclusory 16 opinion, unrelated to Tapia’s expert’s opinions. Specifically, he claims that Dr. Nanton offered a 17 new opinion when he stated, “Because of the unusual nature of Mr. Tapia’s presentation, even 18 with the benefit of hindsight, it is my opinion that that the development of a blood clot resulting in 19 his need for an amputation was not foreseeable.” Dkt. No. 116 at 4 (quoting Dkt. No. 117-20 at 20 7). 21 This is not a new opinion. Rather, this opinion is responsive to Tapia’s experts’ 22 conclusions that Tapia was experiencing delirium potentially from the blood clot and that such 23
6 The Court’s conclusion also moots Tapia’s footnoted argument that Dr. Nanton’s rebuttal regarding life expectancy 24 is unreliable. Dkt. No. 116 at 4 n.2. 1 mental health changes should have led to escalated care. Dkt. No. 104-5 at 32, Dkt. No. 104-8 at 2 8 (“Mr. Tapia’s sudden altered mental status…should have set off alarm bells and led to the 3 immediate transfer or referral of the patient to medical for evaluation.”). The “Summary” section
4 sufficiently contradicts Tapia’s experts’ opinions and thus, is proper rebuttal. However, the 5 concept of “foreseeability” is a legal conclusion, and Dr. Nanton will not be permitted to testify to 6 legal conclusions. Hangarter, 373 F.3d at 1016 (“[A]n expert witness cannot give an opinion as 7 to [their] legal conclusion, i.e., an opinion on an ultimate issue of law.”). 8 Accordingly, the Court grants in part and denies in part Tapia’s motion to exclude Dr. 9 Nanton. The Court excludes the “Drug-Induced Psychosis” and “Life Expectancy” sections of Dr. 10 Nanton’s rebuttal report, but finds that his remaining testimony is admissible subject to the 11 restriction noted above. 12 2. Dr. Kaj Johansen
13 Dr. Kaj Johansen is a licensed, board-certified vascular surgeon. Dkt. No. 117-22 at 3. He 14 is retired from clinical practice, but previously served as the attending surgeon at the Cherry Hill 15 and First Hill Campuses/Swedish Medical Center in Seattle. Id. He currently serves as a clinical 16 professor of surgery at the University of Washington School of Medicine. Id. Dr. Johansen 17 previously served as the director and chief of vascular surgery at various medical centers in Seattle. 18 Id. at 1. 19 Tapia moves to strike as unreliable and prejudicial Dr. Johansen’s opinions on the 20 standards of care for nurses and MHPs. According to Tapia, Dr. Johansen is unqualified to provide 21 opinions on nursing, mental health, or correctional health care. Id. at 6. Tapia also asserts that Dr. 22 Johansen attempts to “rela[y] character assessments” by characterizing Tapia’s allegations as
23 “disingenuous.” Id. at 7. In response, Pierce County argues that Dr. Johansen has not provided 24 opinions on nursing or mental health standards, and instead only provides opinions on the 1 development of Tapia’s DVT and PCD. Dkt. No. 128 at 4. Pierce County asserts that, at most, 2 Dr. Johansen described how Tapia presented to mental health and nursing staff. Id. 3 The Court disagrees with Pierce County. In his rebuttal report, Dr. Johansen concludes
4 that from September 15 to September 29, Tapia displayed “no abnormalities so noteworthy that 5 they should have warranted a further and more detailed assessment[.]” Dkt. No. 117-23 at 5. This 6 statement goes beyond merely reiterating the MHPs and nurses’ observations; rather, Dr. Johansen 7 provided an opinion on whether the mental health and nursing staff should have escalated Tapia’s 8 case, ultimately concluding that their lack of referral was warranted. As such, to the extent Dr. 9 Johansen’s opinions go to whether the MHPs and nurses acted according to mental health and 10 nursing standards of care, they will be excluded. See, e.g., Dkt. No. 117-28 at 9 (“Evaluation prior 11 to [October 1, 2018] would likely have demonstrated simply a swollen foot with normal arterial 12 pulses, not likely triggering any further assessment or intervention at that time.”).
13 The Court also agrees that Dr. Johansen’s characterization of Tapia’s allegations in the 14 Second Amended Complaint as “disingenuous” should be stricken. Dkt. No. 117-28 at 8. Such 15 character assessments are not the proper subject for expert testimony as they are unhelpful to the 16 fact-finder and infringe upon the jury’s role. United States v. Nguyen, No. 05-10576, 2006 U.S. 17 App. LEXIS 17395, at *2 (9th Cir. July 10, 2006); Rhine, 2022 WL 7729817, at *4. 18 As a result, the Court grants Tapia’s motion to exclude portions of Dr. Johansen’s 19 testimony. The Court excludes Dr. Johansen’s opinions that go to whether the MHPs and nursing 20 staff properly assessed and monitored Tapia. The Court also excludes Dr. Johansen’s statements 21 regarding whether Tapia’s allegations were “disingenuous.” Dkt. No. 117-28 at 8. 22 3. Dr. Molly Timmerman
23 Dr. Molly Timmerman is a board-certified physical medicine and rehabilitation physician, 24 with a clinical focus in amputation medicine. Dkt. No. 117-25 at 2. She currently practices 1 amputation medicine at the Veterans Health Administration in Palo Alto and serves as the medical 2 director at the Regional Amputation Center. Id. She has experience directing lifetime prosthetic 3 and rehabilitation care to patients with amputations and is an affiliated clinical assistant professor
4 at Stanford University Orthopedic Surgery/Physical Medicine and Rehabilitation Department. Id. 5 In her rebuttal report, Dr. Timmerman stated: 6 I defer the necessity of psychological needs to a psychiatry expert; however, I do note that physical and rehabilitation medicine providers such as myself and Dr. 7 Carlson do not typically diagnose mental health condition [sic] and determine the proper cause of treatment. Rather, we refer patients to mental health providers for 8 evaluation should we be concerned.
9 Dkt. No. 117-25 at 9. Tapia contends that this statement is improper because it offers an opinion 10 on Dr. Carlson’s qualifications to opine on Tapia’s future mental health needs and provides an 11 improper legal conclusion. Dkt. No. 116 at 8. Pierce County does not respond to this argument. 12 Tapia is correct. Dr. Timmerman’s opinion does not go to whether any NaphCare or Pierce County 13 employee provided adequate medical care to Tapia. Rather, this conclusion challenges Dr. 14 Carlson’s qualifications to diagnose mental health conditions and relatedly, to opine on Tapia’s 15 mental health care in this instant case. Such opinions constitute impermissible legal conclusions 16 and should be excluded. See United States v. Diaz, 876 F.3d 1194, 1197 (9th Cir. 2017) 17 (reaffirming rule that experts may not provide testimony going to an “ultimate issue”). 18 Tapia also contends that Dr. Timmerman presents conclusory opinions without support 19 from medical literature, research, or other citations. Dkt. No. 116 at 8. Specifically, Tapia 20 challenges Dr. Timmerman’s opinion that Tapia’s condition does not require a pain management 21 subspecialist because “[t]here is no evidence to suggest that Mr. Tapia has an especially 22 complicated pain condition that would require a sub-specialist.” Dkt. No. 117-25 at 8. 23 Though Dr. Timmerman does not include detailed citations in support of her opinions, she 24 has adequately explained the basis for her opinion and her training and experience demonstrates 1 adequate reliability. For example, in support of her conclusion that a pain management 2 subspeciality is unnecessary, she pointed to Dr. Carlson’s interview with Tapia, in which he 3 indicated that Tapia was not currently on any pain medications, though he previously used
4 gabapentin. Id. She also explained that pain management falls within the scope of training of 5 physical medicine and rehabilitation physicians—which is her demonstrated field of expertise. 6 Dkt. No. 117-25 at 2. 7 As such, the Court grants in part and denies in part Tapia’s motion to exclude Dr. 8 Timmerman’s rebuttal testimony. 9 4. Gary Berke 10 Gary Berke is a certified prosthetist with 37 years of experience. Dkt. No. 117-24 at 2. He 11 is certified in orthotics, prosthetics, and pedorthotics. Id. He has consulting experience at various 12 clinics, and currently serves as an Adjunct Clinical Associate Professor at Stanford University. Id.
13 In this position, he instructs medical students and professionals about prosthetics and amputation. 14 Id. 15 Tapia argues that Mr. Berke improperly proposes conclusory rebuttal opinions that should 16 be excluded. Dkt. No. 116 at 7-8. First, Tapia takes issue with Mr. Berke’s disagreement with Dr. 17 Volkov’s conclusion “that Mr. Tapia’s amputation was the cause of him doing fewer hours of 18 household services.” Dkt. No. 117-24 at 5. According to Tapia, this conclusion is problematic 19 because Mr. Berke only based this conclusion on Tapia’s “K3 level ambulator” status and Mr. 20 Berke’s unsupported statement that “K3 level ambulators have the physical strength, balance, and 21 capability to participate in recreational activities[.]” Id. Tapia argues that Mr. Berke does not 22 provide any authority for this proposition, while simultaneously disregarding interview data from
23 Tapia explaining his decreases in ability to perform household services. Dkt. No. 146 at 2. 24 1 However, a holistic review of Mr. Berke’s rebuttal shows that Mr. Berke has sufficiently 2 explained the connection between a K3 level ambulator status and potential limitations on ability 3 to provide household services. For example, in Mr. Berke’s rebuttal report, he summarizes Tapia’s
4 medical records from a prosthetics clinic and explains the meaning of “K3 level ambulator,” which 5 he states is consistent with Dr. Carlson’s observation of Tapia’s range of motion and abilities. Dkt. 6 No. 117-24 at 3; Dkt. No. 127-4 at 5. Mr. Berke also reviewed and relied on Tapia’s testimony 7 regarding his vocational activities and hobbies. Id. at 5. Mr. Berke expressly states that this 8 information on Tapia’s mobility—as described by Tapia and in Dr. Carlson’s report—led him to 9 the conclusion that Tapia should be able to perform household services, including bending and 10 kneeling occasionally. Id. Mr. Berke’s explanation of his sources, in combination with his 11 experience and qualifications, is sufficient to satisfy Daubert’s reliability requirements. 12 Accordingly, the Court denies Tapia’s motion to exclude Gary Berke’s testimony.
13 5. Shelley Lewis 14 Shelley Lewis is certified as a rehabilitation counselor, life care planner, and vocational 15 expert. Dkt. No. 117-26 at 48. She currently owns and manages a rehabilitation counseling 16 facility. Id. She holds a Master’s degree in Rehabilitation Counseling and a Bachelor’s degree in 17 Sociology. Id. 18 First, Tapia takes issue with Lewis’ opinion that “[a]side from Mr. Tapia’s legal history, 19 there are other factors that may also have negatively impacted his ongoing earning capacity 20 including his use/abuse of alcohol and illegal drugs.” Dkt. No. 117-26 at 15. Tapia argues that 21 Lewis is unqualified to offer such opinions related to substance abuse because she is not an 22 addiction specialist. Dkt. No. 116 at 9. Likewise, Tapia asserts that Lewis should not offer
23 opinions on criminology or criminality because she lacks expertise in these areas and does not 24 support her opinions with a clear methodology or sufficient facts. Id. at 10. 1 Despite Tapia’s arguments, Lewis is qualified to opine on the effects of Tapia’s drug and 2 criminal history on his employability. Tapia does not seriously challenge her expertise as a 3 vocational rehabilitation counselor, or the underlying methodologies she cites in her rebuttal
4 report. Dkt. No. 116 at 9, Dkt. No. 117-26 at 3 (describing Lewis’ qualifications and her reliance 5 on RAPEL7 methodologies), 31–43 (summary of Lewis’ sources on the effects of criminality and 6 substance use on employability). To the extent Tapia seeks to exclude Lewis’ statements based 7 on their prejudicial nature, such arguments are better suited for a motion in limine. 8 Second, Tapia contends that portions of Lewis’ report should be excluded because they do 9 not properly rebut any other expert opinion. Dkt. No. 116 at 10. Tapia seeks to exclude the first 10 17 pages of Lewis’ report, arguing that this portion provides Lewis’ opinions, a review of the 11 records, and no reference to Tapia’s experts. Tapia is incorrect. Whether the rebuttal expert 12 references or cites the opposing expert is not determinative of whether their rebuttal report is 13 proper. Theoharis v. Rongen, No. C13-1345RAJ, 2014 WL 3563386, at *4 (W.D. Wash. July 18, 14 2014) (citing Lindner v. Meadow Gold Dairies, Inc., 249 F.R.D. 625, 636 (D. Haw. 2008)). 15 Rather, the Court finds that Lewis’ report sufficiently contradicts Mr. Andenmatten’s 16 opinion on loss of earnings. Compare Dkt. No. 117-26 at 15–18 (finding that $42,640 annual 17 salary represents Tapia’s current earning capacity plus annual cost of living increases over time 18 and that Tapia has “not experienced any impact on his ability to earn wages”), with Dkt. No. 127- 19 9 at 57 (Andenmatten’s conclusion that $52,788 annual salary was Tapia’s pre-injury earning 20 capacity and that Tapia will suffer a partial loss of $10,148 annually if he maintains his current 21 22
23 7 RAPEL stands for “Rehabilitation Plan, Access to Labor Market, Placability, Earning Capacity, Labor Force Participation” and has been used by vocational experts in courts to assess earning capacity in vocational rehabilitation. Petersen v. United States, No. 1:21-cv-00097-AKB, 2024 WL 1116161, at *1 (D. Idaho Mar. 14, 2024). 24 1 employment). And Lewis also provides an alternative life care plan which diverges from Dr. 2 Carlson’s. See Dkt. No. 117-26 at 20–29. These portions of her report are proper rebuttal. 3 That said, some of Lewis’ report is not proper rebuttal testimony. At trial, Lewis cannot
4 testify about her review of the record except as to support her rebuttal opinions. See, e.g., 5 Theoharis, 2014 WL 3563386, at *5. She may not testify as to Tapia’s potential current and future 6 drug use because such assessments are beyond the scope of her rebuttal. See id. However, she 7 may opine on how Tapia’s past criminal and drug history impacted his past employment and how 8 such facts may affect his future earning capacity because this issue was referenced by Tapia’s 9 experts. Dkt. No. 127-8 at 4, 5; Dkt. No. 127-9 at 28. 10 Finally, again, in a footnote, Tapia claims that Pierce County improperly disclosed Lewis’ 11 rebuttal report and “challenges the sufficiency of Pierce County’s disclosure under Fed. R. 26.” 12 Dkt. No. 116 at 10 n.4. This is the third time Tapia has attempted to assert substantive arguments
13 in the footnotes of his motions. Moreover, Tapia provides no explanation for this argument beyond 14 this conclusory statement. As such, the Court exercises its discretion to disregard Tapia’s 15 allegation of improper disclosure. Myers v. Alstead, No. C16-1580 RAJ, 2017 WL 3872408, at 16 *2 n.2 (W.D. Wash. Sept. 5, 2017) (“When parties leave arguments in footnotes, it suggests to the 17 Court that the arguments do not hold much weight.”). 18 As a result, the Court grants in part and denies in part Tapia’s motion to exclude Shelley 19 Lewis. 20 6. Eric Knowles 21 Eric Knowles is an economist, with a Master’s and Bachelor’s degree in Business 22 Administration. Dkt. No. 117-27 at 17. He owns the Knowles Group, an economic consulting
23 firm. Dkt. 116-27 at 16-17. Tapia seeks to exclude portions of Knowles’ testimony on two bases. 24 1 First, Tapia argues that Knowles provided a legal conclusion when he stated that Dr. 2 Volkov was “unqualified” to calculate Tapia’s loss of household services. Dkt. No. 116 at 11. 3 Like with Dr. Timmerman, the Court precludes Knowles from testifying as to whether other
4 experts are qualified to testify in this case because whether Dr. Volkov is sufficiently qualified to 5 pass the Daubert test is the Court’s decision. See Diaz, 876 F.3d at 1197. 6 Second, Tapia asserts that Knowles is “unqualified to opine on the effects of past drug use 7 or the impacts of past incarcerations or convictions on life expectancy and work-life expectancy.” 8 Dkt. No. 146 at 6. Throughout his report, Knowles relies on Dr. Abrams’ life expectancy estimate 9 of 53 years. Dkt. No. 117-27 at 8, 10, 13. He uses Dr. Abrams’ estimate to critique Dr. Volkov’s 10 earnings loss assessment and loss of household services calculation. Id. at 8. Knowles also uses 11 Dr. Abrams’ estimate to calculate the present value of Lewis’ life care plan. Id. at 13. Tapia 12 argues that Knowles’ reliance on Dr. Abrams’ report is problematic because Knowles did not (1)
13 conduct an independent analysis or rely on other sources to show that Dr. Abrams’ estimate is 14 reliable or (2) show that economists would widely accept Dr. Abrams’ methodology and data when 15 calculating economic loss. Id. at 6. 16 The mere fact that Knowles relied on other experts is not basis for exclusion. See Fed. R. 17 Evid. 703 (“An expert may base an opinion on facts or data in the case that the expert has been 18 made aware of or personally observed.”); Paeschke v. Gen. Motors LLC, 4:16-CV-5050-LRS, 19 2017 WL 4003382, at *3 (E.D. Wash. Aug. 18, 2017) (“The facts and data upon which an expert 20 may rely in reaching an expert opinion includes the opinions and findings of other experts, if 21 experts in their respective field would reasonably rely on other expert’s opinions and findings.”). 22 However, “[a]n expert’s sole or primary reliance on the opinions of other experts raises serious
23 reliability questions.” In re Conagra Foods, Inc., 302 F.R.D. 537, 556 (C.D. Cal. 2014) (citing 24 Fosmire v. Progressive Max Ins. Co., 277 F.R.D. 625, 629 (W.D. Wash. 2011)). An expert may 1 not “rely exclusively” on another expert’s opinion, but rather must demonstrate that his opinions 2 are informed by his direct experience, observations, and facts in the record. Guadiana v. State 3 Farm Fire & Cas. Co., No. CIV 07-326 TUC FRZ (LAB), 2013 WL 1217621, *4 (D. Ariz. Oct.
4 18, 2013). 5 Here, Knowles does not provide an adequate basis for his reliance of Dr. Abrams’ life 6 expectancy estimate. He agrees with Dr. Abrams’ conclusion that Tapia’s life expectancy should 7 be shortened to 53 years due to Tapia’s past drug use, but he cites no other sources that support 8 such a reduction. And Knowles does not explain what parts of the record he believes supports or 9 concurs with Dr. Abrams’ conclusion. At most, Knowles cites two Journal of Forensic Economics 10 articles which “quantify the impact of past conviction and incarceration on future losses of income 11 and work-life.” Dkt. No. 117-27 at 12. While these articles support Knowles’ conclusion that 12 Tapia’s work-life expectancy is impacted by his criminal history, they do not go to why his life
13 expectancy should be shortened and by how much. Moreover, unlike Dr. Abrams, who is an 14 addiction specialist, Knowles is not informed by direct experience or observations of individuals 15 facing chronic drug abuse. Overall, it appears that Knowles relied exclusively on Dr. Abrams’ 16 report. 17 As such, the Court excludes Knowles’ testimony that relied on Dr. Abrams’ life expectancy 18 estimate. 19 IV. CONCLUSION 20 Accordingly, Defendants’ motions to exclude Tapia’s experts (Dkt. Nos. 109, 111, 113) 21 are decided as follows. The motion to exclude: 22 • Dr. Johnny Bates is DENIED;
23 • Dr. Denise Glindmeyer is DENIED; 24 • Denise Panosky is DENIED; 1 • Dr. Juan Carlos Jimenez is DENIED; 2 • Dr. Hans Carlson is GRANTED IN PART AND DENIED IN PART; 3 • Timothy Andenmatten is DENIED; and
4 • Dr. Nik Volkov is DENIED. 5 Further, the Court ORDERS Tapia to disclose Dr. Carlson’s Physician Consultation Report and 6 Physician Capacity Evaluation. Tapia must provide this information within 7 days of this order 7 and pay the costs of any additional deposition as directed above. 8 Tapia’s motion to exclude NaphCare’s experts (Dkt. No. 115) is decided as follows. The 9 motion to exclude: 10 • Dr. Alan Abrams is DENIED; 11 • Dr. Peter Crum is GRANTED IN PART and DENIED IN PART; 12 • Kathryn Wild is DENIED; and
13 • Dr. Benjamin Starnes is DENIED. 14 Tapia’s motion to exclude Pierce County’s experts (Dkt. No. 116) is decided as follows. 15 The motion to exclude: 16 • Dr. Andrew Nanton is GRANTED IN PART and DENIED IN PART; 17 • Dr. Kaj Johansen is GRANTED; 18 • Dr. Molly Timmerman is GRANTED IN PART and DENIED IN PART; 19 • Gary Berke is DENIED; 20 • Shelley Lewis is GRANTED IN PART and DENIED IN PART, and 21
24 1 • Eric Knowles is GRANTED. 2 3 Dated this 7th day of February, 2025.
4 a 5 Kymberly K. Evanson 6 United States District Judge
7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24
Tapia v. NaphCare Inc (Tapia v. NaphCare Inc) — published by Counsel Stack Legal Research, free access to 12M+ legal documents.